CA2122363C - Coated composite material with wettable surface - Google Patents
Coated composite material with wettable surface Download PDFInfo
- Publication number
- CA2122363C CA2122363C CA002122363A CA2122363A CA2122363C CA 2122363 C CA2122363 C CA 2122363C CA 002122363 A CA002122363 A CA 002122363A CA 2122363 A CA2122363 A CA 2122363A CA 2122363 C CA2122363 C CA 2122363C
- Authority
- CA
- Canada
- Prior art keywords
- carbohydrate
- composite material
- amino groups
- base material
- groups
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002131 composite material Substances 0.000 title claims abstract description 41
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 84
- 125000003277 amino group Chemical group 0.000 claims abstract description 39
- 238000000034 method Methods 0.000 claims abstract description 33
- 238000000576 coating method Methods 0.000 claims abstract description 28
- 239000011248 coating agent Substances 0.000 claims abstract description 27
- 239000012530 fluid Substances 0.000 claims abstract description 17
- 230000008569 process Effects 0.000 claims abstract description 15
- 238000004519 manufacturing process Methods 0.000 claims abstract description 12
- 239000000463 material Substances 0.000 claims description 83
- 229920002307 Dextran Polymers 0.000 claims description 50
- -1 polysaccharide carbohydrate Chemical class 0.000 claims description 33
- 150000004676 glycans Chemical class 0.000 claims description 25
- 229920001282 polysaccharide Polymers 0.000 claims description 25
- 239000005017 polysaccharide Substances 0.000 claims description 25
- 229920001661 Chitosan Polymers 0.000 claims description 18
- 125000004432 carbon atom Chemical group C* 0.000 claims description 15
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 13
- 229920002674 hyaluronan Polymers 0.000 claims description 12
- 229960003160 hyaluronic acid Drugs 0.000 claims description 12
- 229920000855 Fucoidan Polymers 0.000 claims description 10
- 238000004381 surface treatment Methods 0.000 claims description 10
- 150000001412 amines Chemical class 0.000 claims description 9
- WJYIASZWHGOTOU-UHFFFAOYSA-N Heptylamine Chemical group CCCCCCCN WJYIASZWHGOTOU-UHFFFAOYSA-N 0.000 claims description 8
- 239000003153 chemical reaction reagent Substances 0.000 claims description 8
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical group CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 claims description 6
- BAVYZALUXZFZLV-UHFFFAOYSA-N mono-methylamine Natural products NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 claims description 4
- 150000003973 alkyl amines Chemical class 0.000 claims 8
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 abstract description 41
- 125000000524 functional group Chemical group 0.000 abstract description 32
- 239000013590 bulk material Substances 0.000 abstract description 29
- 238000002360 preparation method Methods 0.000 abstract description 13
- 235000014633 carbohydrates Nutrition 0.000 description 72
- 210000002381 plasma Anatomy 0.000 description 62
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 38
- 239000010408 film Substances 0.000 description 25
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 21
- 239000000758 substrate Substances 0.000 description 21
- 239000010410 layer Substances 0.000 description 20
- 239000000243 solution Substances 0.000 description 20
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 18
- 229920000642 polymer Polymers 0.000 description 18
- 239000007789 gas Substances 0.000 description 16
- 238000006243 chemical reaction Methods 0.000 description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- 244000309464 bull Species 0.000 description 14
- 125000005442 diisocyanate group Chemical group 0.000 description 14
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 12
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical compound C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 description 12
- 125000000217 alkyl group Chemical group 0.000 description 10
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000012153 distilled water Substances 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 238000009832 plasma treatment Methods 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 8
- 230000009257 reactivity Effects 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 7
- 230000001588 bifunctional effect Effects 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000005062 Polybutadiene Substances 0.000 description 6
- 239000004372 Polyvinyl alcohol Substances 0.000 description 6
- 229910021529 ammonia Inorganic materials 0.000 description 6
- 125000003118 aryl group Chemical group 0.000 description 6
- MSWZFWKMSRAUBD-QZABAPFNSA-N beta-D-glucosamine Chemical compound N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-QZABAPFNSA-N 0.000 description 6
- 125000001261 isocyanato group Chemical group *N=C=O 0.000 description 6
- NIMLQBUJDJZYEJ-UHFFFAOYSA-N isophorone diisocyanate Chemical compound CC1(C)CC(N=C=O)CC(C)(CN=C=O)C1 NIMLQBUJDJZYEJ-UHFFFAOYSA-N 0.000 description 6
- 230000014759 maintenance of location Effects 0.000 description 6
- 230000004048 modification Effects 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- 229920002857 polybutadiene Polymers 0.000 description 6
- 229920001296 polysiloxane Polymers 0.000 description 6
- 229920002451 polyvinyl alcohol Polymers 0.000 description 6
- DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical compound CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 description 6
- 239000005058 Isophorone diisocyanate Substances 0.000 description 5
- UKLDJPRMSDWDSL-UHFFFAOYSA-L [dibutyl(dodecanoyloxy)stannyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)O[Sn](CCCC)(CCCC)OC(=O)CCCCCCCCCCC UKLDJPRMSDWDSL-UHFFFAOYSA-L 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 125000001931 aliphatic group Chemical group 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 5
- 239000003054 catalyst Substances 0.000 description 5
- 125000003700 epoxy group Chemical group 0.000 description 5
- 125000005843 halogen group Chemical group 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 238000006116 polymerization reaction Methods 0.000 description 5
- 238000002791 soaking Methods 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 4
- 239000004812 Fluorinated ethylene propylene Substances 0.000 description 4
- 229920002683 Glycosaminoglycan Polymers 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 150000001299 aldehydes Chemical class 0.000 description 4
- 125000002947 alkylene group Chemical group 0.000 description 4
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 4
- 238000005266 casting Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- HQQADJVZYDDRJT-UHFFFAOYSA-N ethene;prop-1-ene Chemical group C=C.CC=C HQQADJVZYDDRJT-UHFFFAOYSA-N 0.000 description 4
- 239000011888 foil Substances 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 229920009441 perflouroethylene propylene Polymers 0.000 description 4
- 229920002379 silicone rubber Polymers 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000002792 vascular Effects 0.000 description 4
- YSYRISKCBOPJRG-UHFFFAOYSA-N 4,5-difluoro-2,2-bis(trifluoromethyl)-1,3-dioxole Chemical compound FC1=C(F)OC(C(F)(F)F)(C(F)(F)F)O1 YSYRISKCBOPJRG-UHFFFAOYSA-N 0.000 description 3
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 3
- 239000004593 Epoxy Substances 0.000 description 3
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 3
- 239000005977 Ethylene Substances 0.000 description 3
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000004809 Teflon Substances 0.000 description 3
- 229920006362 Teflon® Polymers 0.000 description 3
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 125000003172 aldehyde group Chemical group 0.000 description 3
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 3
- 150000001721 carbon Chemical group 0.000 description 3
- 125000003636 chemical group Chemical group 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 229960004132 diethyl ether Drugs 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 229940093476 ethylene glycol Drugs 0.000 description 3
- 210000000744 eyelid Anatomy 0.000 description 3
- 229920002313 fluoropolymer Polymers 0.000 description 3
- 239000004811 fluoropolymer Substances 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- 150000004804 polysaccharides Polymers 0.000 description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 3
- 239000004810 polytetrafluoroethylene Substances 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 3
- 239000010409 thin film Substances 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- SHKUUQIDMUMQQK-UHFFFAOYSA-N 2-[4-(oxiran-2-ylmethoxy)butoxymethyl]oxirane Chemical compound C1OC1COCCCCOCC1CO1 SHKUUQIDMUMQQK-UHFFFAOYSA-N 0.000 description 2
- OECTYKWYRCHAKR-UHFFFAOYSA-N 4-vinylcyclohexene dioxide Chemical compound C1OC1C1CC2OC2CC1 OECTYKWYRCHAKR-UHFFFAOYSA-N 0.000 description 2
- RBHIUNHSNSQJNG-UHFFFAOYSA-N 6-methyl-3-(2-methyloxiran-2-yl)-7-oxabicyclo[4.1.0]heptane Chemical compound C1CC2(C)OC2CC1C1(C)CO1 RBHIUNHSNSQJNG-UHFFFAOYSA-N 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- ZFIVKAOQEXOYFY-UHFFFAOYSA-N Diepoxybutane Chemical compound C1OC1C1OC1 ZFIVKAOQEXOYFY-UHFFFAOYSA-N 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 2
- 229920001202 Inulin Polymers 0.000 description 2
- SHZGCJCMOBCMKK-PQMKYFCFSA-N L-Fucose Natural products C[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O SHZGCJCMOBCMKK-PQMKYFCFSA-N 0.000 description 2
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 2
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 229920001543 Laminarin Polymers 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 241000935974 Paralichthys dentatus Species 0.000 description 2
- 229920002230 Pectic acid Polymers 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
- 239000012670 alkaline solution Substances 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- AEMOLEFTQBMNLQ-UHFFFAOYSA-N beta-D-galactopyranuronic acid Natural products OC1OC(C(O)=O)C(O)C(O)C1O AEMOLEFTQBMNLQ-UHFFFAOYSA-N 0.000 description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 239000004305 biphenyl Substances 0.000 description 2
- PXKLMJQFEQBVLD-UHFFFAOYSA-N bisphenol F Chemical compound C1=CC(O)=CC=C1CC1=CC=C(O)C=C1 PXKLMJQFEQBVLD-UHFFFAOYSA-N 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229920006037 cross link polymer Polymers 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 150000002118 epoxides Chemical group 0.000 description 2
- 238000005530 etching Methods 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000009501 film coating Methods 0.000 description 2
- 229960002442 glucosamine Drugs 0.000 description 2
- 229940097043 glucuronic acid Drugs 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 229940091173 hydantoin Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 150000002484 inorganic compounds Chemical class 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 2
- 229940029339 inulin Drugs 0.000 description 2
- 239000012948 isocyanate Substances 0.000 description 2
- HJOVHMDZYOCNQW-UHFFFAOYSA-N isophorone Chemical compound CC1=CC(=O)CC(C)(C)C1 HJOVHMDZYOCNQW-UHFFFAOYSA-N 0.000 description 2
- BQINXKOTJQCISL-GRCPKETISA-N keto-neuraminic acid Chemical compound OC(=O)C(=O)C[C@H](O)[C@@H](N)[C@@H](O)[C@H](O)[C@H](O)CO BQINXKOTJQCISL-GRCPKETISA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- DBTMGCOVALSLOR-VPNXCSTESA-N laminarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1O[C@@H]1[C@@H](O)C(O[C@H]2[C@@H]([C@@H](CO)OC(O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-VPNXCSTESA-N 0.000 description 2
- 125000005647 linker group Chemical group 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- CERZMXAJYMMUDR-UHFFFAOYSA-N neuraminic acid Natural products NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO CERZMXAJYMMUDR-UHFFFAOYSA-N 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 239000010318 polygalacturonic acid Substances 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229920006268 silicone film Polymers 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- UWHCKJMYHZGTIT-UHFFFAOYSA-N tetraethylene glycol Chemical compound OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000012876 topography Methods 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- QNODIIQQMGDSEF-UHFFFAOYSA-N (1-hydroxycyclohexyl)-phenylmethanone Chemical compound C=1C=CC=CC=1C(=O)C1(O)CCCCC1 QNODIIQQMGDSEF-UHFFFAOYSA-N 0.000 description 1
- WOGVOIWHWZWYOZ-UHFFFAOYSA-N 1,1-diisocyanatoethane Chemical compound O=C=NC(C)N=C=O WOGVOIWHWZWYOZ-UHFFFAOYSA-N 0.000 description 1
- XSCLFFBWRKTMTE-UHFFFAOYSA-N 1,3-bis(isocyanatomethyl)cyclohexane Chemical compound O=C=NCC1CCCC(CN=C=O)C1 XSCLFFBWRKTMTE-UHFFFAOYSA-N 0.000 description 1
- JFRQLKNEDLLXOQ-UHFFFAOYSA-N 1,3-diisocyanato-2,4-dimethylbenzene Chemical compound CC1=CC=C(N=C=O)C(C)=C1N=C=O JFRQLKNEDLLXOQ-UHFFFAOYSA-N 0.000 description 1
- ABADUMLIAZCWJD-UHFFFAOYSA-N 1,3-dioxole Chemical class C1OC=CO1 ABADUMLIAZCWJD-UHFFFAOYSA-N 0.000 description 1
- AGJCSCSSMFRMFQ-UHFFFAOYSA-N 1,4-bis(2-isocyanatopropan-2-yl)benzene Chemical compound O=C=NC(C)(C)C1=CC=C(C(C)(C)N=C=O)C=C1 AGJCSCSSMFRMFQ-UHFFFAOYSA-N 0.000 description 1
- CDMDQYCEEKCBGR-UHFFFAOYSA-N 1,4-diisocyanatocyclohexane Chemical compound O=C=NC1CCC(N=C=O)CC1 CDMDQYCEEKCBGR-UHFFFAOYSA-N 0.000 description 1
- SBJCUZQNHOLYMD-UHFFFAOYSA-N 1,5-Naphthalene diisocyanate Chemical compound C1=CC=C2C(N=C=O)=CC=CC2=C1N=C=O SBJCUZQNHOLYMD-UHFFFAOYSA-N 0.000 description 1
- ATOUXIOKEJWULN-UHFFFAOYSA-N 1,6-diisocyanato-2,2,4-trimethylhexane Chemical compound O=C=NCCC(C)CC(C)(C)CN=C=O ATOUXIOKEJWULN-UHFFFAOYSA-N 0.000 description 1
- SZBXTBGNJLZMHB-UHFFFAOYSA-N 1-chloro-2,4-diisocyanatobenzene Chemical compound ClC1=CC=C(N=C=O)C=C1N=C=O SZBXTBGNJLZMHB-UHFFFAOYSA-N 0.000 description 1
- SIYBFAKKDKDECW-UHFFFAOYSA-N 1-ethoxy-2,4-diisocyanatobenzene Chemical compound CCOC1=CC=C(N=C=O)C=C1N=C=O SIYBFAKKDKDECW-UHFFFAOYSA-N 0.000 description 1
- PAUHLEIGHAUFAK-UHFFFAOYSA-N 1-isocyanato-1-[(1-isocyanatocyclohexyl)methyl]cyclohexane Chemical compound C1CCCCC1(N=C=O)CC1(N=C=O)CCCCC1 PAUHLEIGHAUFAK-UHFFFAOYSA-N 0.000 description 1
- KDLIYVDINLSKGR-UHFFFAOYSA-N 1-isocyanato-4-(4-isocyanatophenoxy)benzene Chemical compound C1=CC(N=C=O)=CC=C1OC1=CC=C(N=C=O)C=C1 KDLIYVDINLSKGR-UHFFFAOYSA-N 0.000 description 1
- CXCHEKCRJQRVNG-UHFFFAOYSA-N 2,2,2-trifluoroethanesulfonyl chloride Chemical compound FC(F)(F)CS(Cl)(=O)=O CXCHEKCRJQRVNG-UHFFFAOYSA-N 0.000 description 1
- QILYSOTYPKBIDW-UHFFFAOYSA-N 2,4-diisocyanato-1-(2-phenylethenyl)benzene Chemical compound O=C=NC1=CC(N=C=O)=CC=C1C=CC1=CC=CC=C1 QILYSOTYPKBIDW-UHFFFAOYSA-N 0.000 description 1
- MOBNLCPBAMKACS-UHFFFAOYSA-N 2-(1-chloroethyl)oxirane Chemical compound CC(Cl)C1CO1 MOBNLCPBAMKACS-UHFFFAOYSA-N 0.000 description 1
- FEBUJFMRSBAMES-UHFFFAOYSA-N 2-[(2-{[3,5-dihydroxy-2-(hydroxymethyl)-6-phosphanyloxan-4-yl]oxy}-3,5-dihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-4-yl)oxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl phosphinite Chemical compound OC1C(O)C(O)C(CO)OC1OCC1C(O)C(OC2C(C(OP)C(O)C(CO)O2)O)C(O)C(OC2C(C(CO)OC(P)C2O)O)O1 FEBUJFMRSBAMES-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- MSFSPUZXLOGKHJ-PGYHGBPZSA-N 2-amino-3-O-[(R)-1-carboxyethyl]-2-deoxy-D-glucopyranose Chemical compound OC(=O)[C@@H](C)O[C@@H]1[C@@H](N)C(O)O[C@H](CO)[C@H]1O MSFSPUZXLOGKHJ-PGYHGBPZSA-N 0.000 description 1
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 description 1
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 description 1
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 1
- PVXPPJIGRGXGCY-TZLCEDOOSA-N 6-O-alpha-D-glucopyranosyl-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)C(O)(CO)O1 PVXPPJIGRGXGCY-TZLCEDOOSA-N 0.000 description 1
- NHJIDZUQMHKGRE-UHFFFAOYSA-N 7-oxabicyclo[4.1.0]heptan-4-yl 2-(7-oxabicyclo[4.1.0]heptan-4-yl)acetate Chemical compound C1CC2OC2CC1OC(=O)CC1CC2OC2CC1 NHJIDZUQMHKGRE-UHFFFAOYSA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000518579 Carea Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 102100026735 Coagulation factor VIII Human genes 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- 244000303965 Cyamopsis psoralioides Species 0.000 description 1
- AEMOLEFTQBMNLQ-DTEWXJGMSA-N D-Galacturonic acid Natural products O[C@@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-DTEWXJGMSA-N 0.000 description 1
- BGWQRWREUZVRGI-OLLRPPRZSA-N D-glucoheptopyranose Chemical compound OC[C@H](O)[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O BGWQRWREUZVRGI-OLLRPPRZSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- SRBFZHDQGSBBOR-SOOFDHNKSA-N D-ribopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@@H]1O SRBFZHDQGSBBOR-SOOFDHNKSA-N 0.000 description 1
- YTBSYETUWUMLBZ-QWWZWVQMSA-N D-threose Chemical compound OC[C@@H](O)[C@H](O)C=O YTBSYETUWUMLBZ-QWWZWVQMSA-N 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 239000005057 Hexamethylene diisocyanate Substances 0.000 description 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
- 101000916644 Homo sapiens Macrophage colony-stimulating factor 1 receptor Proteins 0.000 description 1
- 229920000869 Homopolysaccharide Polymers 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- YPZMPEPLWKRVLD-UHFFFAOYSA-N L-glycero-D-manno-heptose Natural products OCC(O)C(O)C(O)C(O)C(O)C=O YPZMPEPLWKRVLD-UHFFFAOYSA-N 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- JPFGFRMPGVDDGE-UHFFFAOYSA-N Leucrose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)(CO)OC1 JPFGFRMPGVDDGE-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 102100028198 Macrophage colony-stimulating factor 1 receptor Human genes 0.000 description 1
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 1
- 241000872931 Myoporum sandwicense Species 0.000 description 1
- VWYHWAHYVKZKHI-UHFFFAOYSA-N N=C=O.N=C=O.C1=CC(N)=CC=C1C1=CC=C(N)C=C1 Chemical compound N=C=O.N=C=O.C1=CC(N)=CC=C1C1=CC=C(N)C=C1 VWYHWAHYVKZKHI-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 229920001616 Polymacon Polymers 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920002305 Schizophyllan Polymers 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 229920002310 Welan gum Polymers 0.000 description 1
- IWQPVKKGSBGBBS-UHFFFAOYSA-N [O]CC1CO1 Chemical compound [O]CC1CO1 IWQPVKKGSBGBBS-UHFFFAOYSA-N 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 125000004036 acetal group Chemical group 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 150000001266 acyl halides Chemical class 0.000 description 1
- 125000004442 acylamino group Chemical group 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 125000005428 anthryl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C(*)=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- NDKBVBUGCNGSJJ-UHFFFAOYSA-M benzyltrimethylammonium hydroxide Chemical compound [OH-].C[N+](C)(C)CC1=CC=CC=C1 NDKBVBUGCNGSJJ-UHFFFAOYSA-M 0.000 description 1
- 150000001602 bicycloalkyls Chemical group 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000006664 bond formation reaction Methods 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- ZWAJLVLEBYIOTI-UHFFFAOYSA-N cyclohexene oxide Chemical compound C1CCCC2OC21 ZWAJLVLEBYIOTI-UHFFFAOYSA-N 0.000 description 1
- 125000004956 cyclohexylene group Chemical group 0.000 description 1
- RHKZVMUBMXGOLL-UHFFFAOYSA-N cyclopentolate hydrochloride Chemical compound Cl.C1CCCC1(O)C(C(=O)OCCN(C)C)C1=CC=CC=C1 RHKZVMUBMXGOLL-UHFFFAOYSA-N 0.000 description 1
- 229940075144 cylate Drugs 0.000 description 1
- AEMOLEFTQBMNLQ-YBSDWZGDSA-N d-mannuronic acid Chemical compound O[C@@H]1O[C@@H](C(O)=O)[C@H](O)[C@@H](O)[C@H]1O AEMOLEFTQBMNLQ-YBSDWZGDSA-N 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 150000002009 diols Chemical group 0.000 description 1
- CJYQQUPRURWLOW-YDLUHMIOSA-M dmsc Chemical compound [Na+].OP(=O)=O.OP(=O)=O.OP(=O)=O.[O-]P(=O)=O.O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1[C@H]2O CJYQQUPRURWLOW-YDLUHMIOSA-M 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229940052303 ethers for general anesthesia Drugs 0.000 description 1
- WBJINCZRORDGAQ-UHFFFAOYSA-N ethyl formate Chemical compound CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000003055 glycidyl group Chemical group C(C1CO1)* 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000005446 heptyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 150000002433 hydrophilic molecules Chemical class 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 229940054190 hydroxypropyl chitosan Drugs 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 125000000686 lactone group Chemical group 0.000 description 1
- JPFGFRMPGVDDGE-PUVWEJBASA-N leucrose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O)C(O)(CO)OC1 JPFGFRMPGVDDGE-PUVWEJBASA-N 0.000 description 1
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 229910052756 noble gas Inorganic materials 0.000 description 1
- 150000002835 noble gases Chemical class 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 1
- 229920003223 poly(pyromellitimide-1,4-diphenyl ether) Polymers 0.000 description 1
- 239000005056 polyisocyanate Substances 0.000 description 1
- 229920001228 polyisocyanate Polymers 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000003385 ring cleavage reaction Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 150000003461 sulfonyl halides Chemical class 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical group ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- RUELTTOHQODFPA-UHFFFAOYSA-N toluene 2,6-diisocyanate Chemical compound CC1=C(N=C=O)C=CC=C1N=C=O RUELTTOHQODFPA-UHFFFAOYSA-N 0.000 description 1
- 125000005490 tosylate group Chemical group 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Classifications
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
- G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
- G02B1/041—Lenses
- G02B1/043—Contact lenses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
Abstract
The invention is directed to a composite material, especially a biomedical device, e.g. an ophthalmic device, preferably a contact lens, with at least one wettable surface capable of holding a continous layer of aqueous fluid thereon which composite material comprises a bulk material and a hydrophilic coating characterized in that the hydrophilic coating consists of a carbohydrate covalently attached by a hydrolytically stable bond to amino groups at the surface of the bulk material, either directly or via functional groups of an oligofunctional compound, said oligofunctional compound in turn having functional groups being capable of reacting with said amino groups at the surface of the bulk material and with the carbohydrate, wherein said amino groups are either inherently (a priori) present in the bulk material or wherein said amino groups have been attached to the surface of the bulk material by a plasma surface preparation, as well as to a process of manufacture of such a composite material.
Description
Coated Composite Material with Wettable Surface This invention relates to composite materials for biomedical use that possess considerably improved retention of an aqueous layer on the surfaces. The invention also relates to the production of such materials from materials that possess suitable bulk properties, but inadequate retention of an aqueous layer. In a particular aspect, the materials and method of this invention are useful for the fabrication of ophthalmic devices, e.g.
contact lenses.
Background to invention There are many applications of materials where retention of a thin film of aqueous fluid is desirable. For example, the retention of an aqueous fluid layer is beneficial for lubrication of catheters, the retention of an aqueous fluid layer can reduce protein fouling on the surface of pacemakers and artificial vascular grafts, or the retention of an aqueous fluid layer can prevent the colonization of a surface by bacteria as they are unable to attach properly. In another aspect, the facile movement of an eyelid over a contact lens is important for the comfort of the wearer; this sliding motion is facilitated by the presence of a continuous layer of tear fluid on the contact lens, a layer which lubricates the tissue/lens interface. However, clinical tests have shown that currently available contact lenses partially dry out between blinks, thus increasing friction between the eyelid and the lens. The increased friction results in soreness of the eyes and movement of the contact lens. Since the average period between blinks is ca. 12 seconds, it would be advantageous to fabricate a wettable and biocompatible contact lens that can hold a continuous layer of tear fluid for more than 12 seconds. Current biomedical materials do not reach this target;
for instance, contact lenses fabricated from highly water swellable polymer pHEMA retain such a tear layer for approximately 5 seconds only.
Thus materials with wettable and biocompatible surfaces are highly desirable for many applications. The wettability of materials is strongly dependent on the chemical composition of the material surface. In particular, the ability of the surface to hold a continuous layer of an aqueous solution, such as tear fluid, is affected by the composition of the material surface. Early attempts to solve the wettability problem in the ophthalmic WU 94!06485 ~ ~ ~ ~ j ~ ~ PCT/EP93l02420rv4'#
contact lenses.
Background to invention There are many applications of materials where retention of a thin film of aqueous fluid is desirable. For example, the retention of an aqueous fluid layer is beneficial for lubrication of catheters, the retention of an aqueous fluid layer can reduce protein fouling on the surface of pacemakers and artificial vascular grafts, or the retention of an aqueous fluid layer can prevent the colonization of a surface by bacteria as they are unable to attach properly. In another aspect, the facile movement of an eyelid over a contact lens is important for the comfort of the wearer; this sliding motion is facilitated by the presence of a continuous layer of tear fluid on the contact lens, a layer which lubricates the tissue/lens interface. However, clinical tests have shown that currently available contact lenses partially dry out between blinks, thus increasing friction between the eyelid and the lens. The increased friction results in soreness of the eyes and movement of the contact lens. Since the average period between blinks is ca. 12 seconds, it would be advantageous to fabricate a wettable and biocompatible contact lens that can hold a continuous layer of tear fluid for more than 12 seconds. Current biomedical materials do not reach this target;
for instance, contact lenses fabricated from highly water swellable polymer pHEMA retain such a tear layer for approximately 5 seconds only.
Thus materials with wettable and biocompatible surfaces are highly desirable for many applications. The wettability of materials is strongly dependent on the chemical composition of the material surface. In particular, the ability of the surface to hold a continuous layer of an aqueous solution, such as tear fluid, is affected by the composition of the material surface. Early attempts to solve the wettability problem in the ophthalmic WU 94!06485 ~ ~ ~ ~ j ~ ~ PCT/EP93l02420rv4'#
field were based on producing hydrophilic materials. For example, in an attempt to make wettable soft contact lenses, silicone elastomers with pendant epoxy groups were prepared by crosslinking epoxidized silicone compounds (French patent FR 2,622,201, J.M. Frances and G. Wajs). The elastomers were rendered. wettable by grafting glucuronic acid onto the epoxy groups. The disadvantage of incorporating hydrophilic species into polymers by bulls synthesis is that the optimum balance of optical properties (e.g., transparency and refractive index), mechanical properties (e.g. strength, hardness, gas permeability and elasticity) and pa~ocessability of the material obtainable will be worse than conventional materials and may not satisfy the application. The incorporation of hydrophilic monomers is not appropriate for improving the wettability of fluoropolymer- or acrylate-based lenses.
In an attempt to fabricate hard contact leases which are compatible with the cornea and ocular fluid, dextran ester monovinyl compounds have been copolymerised with various acrylates (Japanese patent JP 63/309914; H. Kitaguni et al.). DextranJmethyl methacrylate copolymers have been prepared by graft polymerisation and have yielded wettable contact lenses (Y. Onishi et al. in Contemp. Top: Polym. Sci. 4, 149 ( 1984;). The preparation of dextran ester copolymers by bulls' polymerisation methods offers limited scope for improving the wettability of contact lenses in general. The disadvantage of incorporating hydrophilic compounds into polymers by bulk synthesis' is that the optical properties (e.g., transparency and refiactive index); mechanical properties (e.g., strength, hardness, gas permeability and elasticity) and processability of the material cannot be optimized independently.
A method of modifying the surface of contact lenses has been disclosed in GB
2,163,436 (Halpern): According o said method the lens is coated with a carbohydrate which is then crosslinked either covalendy with a polyisocyanate or electrostatically with a divalent canon. The process results in a crosslinked skin which is not covalently bonded to the lens and will delaminate when subjected to a shearing force e.g. by an eyelid.
An alternative approach has been disclosedin WO 90/04609 (Sepracor). Polymeric substrates; especially polymeric membranes; having reactive groups such as hydxoxy or amino groups at the ends of the polymer chains thereof are reacted with a polyfunctional linker moiety having terminal groups such as epoxy, carbonyl, carboxy, amino, halo, hydroxy; sulfonylhalide, acyl halide, isocyanato, or combinations thereof, which in turn are bonded with a Iigand such as hydroxyethylcellulose or dextran. Since the molecular weight of the polymer chains in the substrate is high, the density of chain ends, especially W~ 94/06485 PCTIEI'93d02420 at the surface, will be low, and therefore the density of grafted polysaccharide chains will be low.
The use of dextran and other carbohydrates for surface modification of polymers has also been reported by WO 83/03977, however, in that case the linker moiety is a silane and articles to be treated such as contact lenses are not disclosed.
Additional prior art is directed to modification of the surfaces of contact lenses (LJS
5,080,924) or,ocular implants ('PTO 93/03776), respectively, wherein amino groups at the surface thereof are reacted with dialdehydes and are then coupled with polysaccharides.
However, the reaction of an aldehyde with the hydroxyl groups of a polysaccharide will yield an acid-Iabile ketal bond:
The above methods till require the presence of the article of a chemically reactive group suitable for the intended covalent reaction: Many materials of interest for ophthalmic applications and implantable biomaterial devices do not possess suitable reactive surface groups, for instance, silicon-based contact lenses and polytetrafluoroethylene vascular grafts. The present invention also comprises methods for the activation of a device surface; the method being generic; so that the surface of any material with suitable bulk properties can be converted to be receptive for the covalent immobilizarion of a coating which'is highly retentious for aqueous layers: In this embodiment of the invention the surface of the polravyeric material is activated preferably by a gas plasma (glow discharge) surface treatment method;
A number of surface treatmient techniques for polymeric materials are known in the art:
Eorona Discharge; Flame ~'reatment, Acid Etching, and a number of other methods intended to perform chemictil modification of the surface: Among the disadvantages of these techniques are the use of or production of hazardous chemicals, the often excessive depth of treatment; non-unif~rmity of treatment at a microscopic level, and often severe etching and pitting hat leads to changes in surface topography. The depth of treatment is important because with clear materials such tis those required for lenses the optical clarity and surface smoothness become affected after an excessively harsh treatment.
'rreatrnent of polymeric surfaces by gas plasmas provides the advantages of very low treatment depth, and uniformity on a microscopic scale. A gas plasma (also known as glow discharge) is produced by electrical discharge in a gas atmosphere at reduced WO 94lOG48S PCT/EP9~/02420 pressure ("vacuum"). It creates a stable, partially ionized gas that may be utilized for effecting reactions on the surface of the substrate because the gas plasma environment activates even chemical compounds that are unreactive under normal conditions.
The treatment intensity at the surface is generally relatively strong, and yet the penetration depth of gas plasma treatment is very low, of the order of 5 to SO nanometres, at a treatment intensity sufficient for useful surface modification. Surface topography and optical clarity do not change unless exposure to the plasma is performed for periods of time much exceeding the time required for achieving the desired chemical mod~cation of the surface. There occurs; therefore, significantly less alteration of the properties of the bulk material than with alternative treatment technologies.
Gas plasma techniques can have wa classes of outcomes. In the first, commonly called plasma surface treatment, the surface of a polymeric material to be treated ("the substrate") is subjected to a plasma established in one or more inorganic vapors or some select organic vapors, and the plasma treatment causes the replacement of some of the original chemical groups on a polymer surface by other; novel groups which are contributed from the plasma gas: For instance, the plasma surface treatment of polytetrafluoroethylene in an ammonia plasma leads o the abstraction of some of the surface fluorine atoms by C-F bond breakage and the incorporation into the modified surface layer of amime groups by C-N bond formation. Plasma surface treatment in an appropriate vapor such as ammonia, carbon dioxide, or water vapor, can therefore be used taplace on the surface of any polymeric material reactive chemical groups, such as amine, carboxyl; or hydroxyl, suitable for the subsequent covalent immobilization of various molecules.
The second type of plasma technique is commonly called plasma polymerization and occurs when a discharge is struck in most organic vapors: In contrast to plasma surface treatment, in which less than a monolayer of new material is added, the technique of plasma polymerization leads to the formation of film coatings which can be several micrometers thick and can completely mask'the substrate.
Plasma polymers are also covalendy bonded to the underlying substrate. The covalent attachment of the plasma coating to the bulk material ensures that the plasma polymer does not detach: Furthermore, plasma polymers are highly crosslinked and do not possess low molecular'weight fragments which might migrate into body tissue or fluids.
WO 94!064$5 PCTlEP93lQ2420 ..,,' 21~?~~~
In an attempt to fabricate hard contact leases which are compatible with the cornea and ocular fluid, dextran ester monovinyl compounds have been copolymerised with various acrylates (Japanese patent JP 63/309914; H. Kitaguni et al.). DextranJmethyl methacrylate copolymers have been prepared by graft polymerisation and have yielded wettable contact lenses (Y. Onishi et al. in Contemp. Top: Polym. Sci. 4, 149 ( 1984;). The preparation of dextran ester copolymers by bulls' polymerisation methods offers limited scope for improving the wettability of contact lenses in general. The disadvantage of incorporating hydrophilic compounds into polymers by bulk synthesis' is that the optical properties (e.g., transparency and refiactive index); mechanical properties (e.g., strength, hardness, gas permeability and elasticity) and processability of the material cannot be optimized independently.
A method of modifying the surface of contact lenses has been disclosed in GB
2,163,436 (Halpern): According o said method the lens is coated with a carbohydrate which is then crosslinked either covalendy with a polyisocyanate or electrostatically with a divalent canon. The process results in a crosslinked skin which is not covalently bonded to the lens and will delaminate when subjected to a shearing force e.g. by an eyelid.
An alternative approach has been disclosedin WO 90/04609 (Sepracor). Polymeric substrates; especially polymeric membranes; having reactive groups such as hydxoxy or amino groups at the ends of the polymer chains thereof are reacted with a polyfunctional linker moiety having terminal groups such as epoxy, carbonyl, carboxy, amino, halo, hydroxy; sulfonylhalide, acyl halide, isocyanato, or combinations thereof, which in turn are bonded with a Iigand such as hydroxyethylcellulose or dextran. Since the molecular weight of the polymer chains in the substrate is high, the density of chain ends, especially W~ 94/06485 PCTIEI'93d02420 at the surface, will be low, and therefore the density of grafted polysaccharide chains will be low.
The use of dextran and other carbohydrates for surface modification of polymers has also been reported by WO 83/03977, however, in that case the linker moiety is a silane and articles to be treated such as contact lenses are not disclosed.
Additional prior art is directed to modification of the surfaces of contact lenses (LJS
5,080,924) or,ocular implants ('PTO 93/03776), respectively, wherein amino groups at the surface thereof are reacted with dialdehydes and are then coupled with polysaccharides.
However, the reaction of an aldehyde with the hydroxyl groups of a polysaccharide will yield an acid-Iabile ketal bond:
The above methods till require the presence of the article of a chemically reactive group suitable for the intended covalent reaction: Many materials of interest for ophthalmic applications and implantable biomaterial devices do not possess suitable reactive surface groups, for instance, silicon-based contact lenses and polytetrafluoroethylene vascular grafts. The present invention also comprises methods for the activation of a device surface; the method being generic; so that the surface of any material with suitable bulk properties can be converted to be receptive for the covalent immobilizarion of a coating which'is highly retentious for aqueous layers: In this embodiment of the invention the surface of the polravyeric material is activated preferably by a gas plasma (glow discharge) surface treatment method;
A number of surface treatmient techniques for polymeric materials are known in the art:
Eorona Discharge; Flame ~'reatment, Acid Etching, and a number of other methods intended to perform chemictil modification of the surface: Among the disadvantages of these techniques are the use of or production of hazardous chemicals, the often excessive depth of treatment; non-unif~rmity of treatment at a microscopic level, and often severe etching and pitting hat leads to changes in surface topography. The depth of treatment is important because with clear materials such tis those required for lenses the optical clarity and surface smoothness become affected after an excessively harsh treatment.
'rreatrnent of polymeric surfaces by gas plasmas provides the advantages of very low treatment depth, and uniformity on a microscopic scale. A gas plasma (also known as glow discharge) is produced by electrical discharge in a gas atmosphere at reduced WO 94lOG48S PCT/EP9~/02420 pressure ("vacuum"). It creates a stable, partially ionized gas that may be utilized for effecting reactions on the surface of the substrate because the gas plasma environment activates even chemical compounds that are unreactive under normal conditions.
The treatment intensity at the surface is generally relatively strong, and yet the penetration depth of gas plasma treatment is very low, of the order of 5 to SO nanometres, at a treatment intensity sufficient for useful surface modification. Surface topography and optical clarity do not change unless exposure to the plasma is performed for periods of time much exceeding the time required for achieving the desired chemical mod~cation of the surface. There occurs; therefore, significantly less alteration of the properties of the bulk material than with alternative treatment technologies.
Gas plasma techniques can have wa classes of outcomes. In the first, commonly called plasma surface treatment, the surface of a polymeric material to be treated ("the substrate") is subjected to a plasma established in one or more inorganic vapors or some select organic vapors, and the plasma treatment causes the replacement of some of the original chemical groups on a polymer surface by other; novel groups which are contributed from the plasma gas: For instance, the plasma surface treatment of polytetrafluoroethylene in an ammonia plasma leads o the abstraction of some of the surface fluorine atoms by C-F bond breakage and the incorporation into the modified surface layer of amime groups by C-N bond formation. Plasma surface treatment in an appropriate vapor such as ammonia, carbon dioxide, or water vapor, can therefore be used taplace on the surface of any polymeric material reactive chemical groups, such as amine, carboxyl; or hydroxyl, suitable for the subsequent covalent immobilization of various molecules.
The second type of plasma technique is commonly called plasma polymerization and occurs when a discharge is struck in most organic vapors: In contrast to plasma surface treatment, in which less than a monolayer of new material is added, the technique of plasma polymerization leads to the formation of film coatings which can be several micrometers thick and can completely mask'the substrate.
Plasma polymers are also covalendy bonded to the underlying substrate. The covalent attachment of the plasma coating to the bulk material ensures that the plasma polymer does not detach: Furthermore, plasma polymers are highly crosslinked and do not possess low molecular'weight fragments which might migrate into body tissue or fluids.
WO 94!064$5 PCTlEP93lQ2420 ..,,' 21~?~~~
By appropriate choice of the monomer vapor and the plasma conditions, plasma polymer coatings can be fabricated to contain specific, chemically reactive groups which are also suitable for the subsequent chemical attachment of various molecules to the surface. In the present invention, the surface of a polymeac material which does not inherently carry suitable reactive groups can be activated by plasma surface treatment, plasma polymerization, or plasma polymerization followed by a subsequent plasma surface treatment, Summary of invention Accordingly, in one aspect, the invention provides a novel composite material, especially a biomedical device, e:g. an ophthalmic device; such as a contact lens, with one or more wettable surfaces capable of holding a continuous layer of aqueous fluid thereon, characterized in that the composite comprises a carbohydrate which is covalently bound by a hydrolytically stable bond to a plasma surface prepared on the base material. Within the context of this invention a plasma surface prepared on a base, or bulls, material comprises either a plasma treated (or modified) surface on a base material or a plasma polymer coated to a base material:-The base material is selected for it's bulls properties, such as mechanical-strengths elasticity; gas permeability, optical clarity, to suit the intended application of the composite.
In a econd aspect, the invention provides a biomedical product which provides enhanced comfort to the wearer; whereby said product is composed of a bulls material and a hydrophilic coating according to the first aspect of the invention. The hydrophilic coating consists of a carbohydrate attached co~alently on to a plasma surface prepared on the bulls material, e:g. a thin, fully covering plasma polymer coating.
In a further aspect the invention provides a composite material, especially a biomedical device, e.g. an ophthalmic de~rice; such as a contact lens, with one or more wettable surfaces capable of holding a continuous layer of aqueous fluidthereon characterized in that the composite comprises a carbohydrate which is covalently bound by a hydrolytieally stable bond to reactive gioups inherently present in the bulk material and at the surface of the biomedical device.
According to these aspects of the invention the carbohydrate is hound to the reactive groups either directly or via an oligofunctional compound having one or more functional groups capable of chemically reacting with the said reactive groups and having at least one additional functional group capable of chemically reacting with a carbohydrate to produce an activated surface.
According to on aspect of the present invention, there is provided a composite material having at least one wettable surface capable of holding a continuous layer of aqueous fluid therein, which material comprises: (a) a bulk base material, and (b) a hydrophilic coating, wherein the hydrophilic coating consists of a carbohydrate directly and covalently attached by a hydrolytically stable bond to amino groups at the surface of the bulk base material, wherein said amino groups are either inherently present in the base material or have been attached to the surface of the bulk base material by plasma surface treatment.
According to another aspect of the present invention, there is provided a process for the manufacture of a wettable composite material with at least one wettable surface capable of holding a continuous layer of aqueous fluid thereon, wherein said composite material includes a bulk base material and a hydrophilic coating of a carbohydrate directly attached covalently by a hydrolytically stable bond to amino groups at the at least one wettable surface of the base material, said process comprising the steps of: (1) covalently attaching amino groups onto the at least one wettable surface of a preformed base material by subjecting the preformed base material to a gas plasma established in a vapor containing at least one amine compoung; (2) optionally treating the carbohydrate with a reagent which modifies said carbohydrate such that said carbohydrate is capable of reacting with the amino groups; (3) reacting said amino groups on the at least one -6a-wettable surface with the carbohydrate to immobilize the carbohydrate onto the at least one wettable surface; and (4) treating the surface-immobilized carbohydrate with a reagent to stabilize the bond between the carbohydrate and the at least one wettable surface, if required to obtain said hydrolytically stable bond.
In yet a further aspect, the invention provides a process for the manufacture of a wettable composite material, especially a biomedical device, e.g. an ophthalmic device, said' process cot»prising the following steps:
1. exposing the non-composite biomedical device in its desired final foam to a low pressure plasma in a vapor of at least one organic andlor inorganic compound under 1 o conditions whereby a thin film containing reactive groups is deposited on the desired surfaces) of the base material, 2. optionally, reacting the said reactive groups with an activating group, and/or with an oligofunctional compound having one or more functional groups capable of chemically reacting with the said reactive gn~ups,.or with the activated reactive groups, and having at least one additsonal functional group capable of chemicaDy reacting with a carbohydrate to produce an activated surface, 3. optionally treating thc-carbohydrate with a reagent which modifies the sand carbohydrate so that it is capable of reacting with the surface reactive or functional groups, 4. reacting the reactive groups or the functional groups with the carbohydrate, 2 0 5. optionally, treating the surface-immobilized carbohydrate with a reagent to stabilizre the bond between the carbohydrate and the surface.
The resulting material is preferably washed and suitably packed ready for use.
In yet a funher aspect, the invention provides a process for the manufacture of a wettable composite material, especially a biomedical device, e.g. an ophthalmic device, having 2 5 reactive groups inherently (a priori) present in the bulk mtiterial, said process comprising the following step(s):
- optionally, reacting the reactive groups inherently present in the bulk material of the non-composite biomedical device in its desired final form with an activating group, and/or with an oligofunctional compound having one or more functional groups capable of 3 o chemically reacting with the said reactive groups, or with the activated reactive groups, and having at least one functional group capable of chemically reacting with a carbohydrate to produce an activated stuface, - optionally treating the carbohydrate with a reagent which modif-~es the said carbohydrate so that it is capable of reacting with the surface reactive or functional groups, _7_ reacting the reactive groups or the functional groups with the carbohydrate, - optionally, treating the surface-immobilized carbohydrate with a reagent to stabilize the bond between the carbohydrate and the surface.
The invention is therefore directed to a composite material, especially a biomedical device, e.g. an ophthalmic device, preferably a contact lens, with one or more wettable surfaces capable of holding a continuous layer of aqueous fluid thereon which composite material comprises a bulk material and a hydrophilic coating characterized in that the hydrophilic coating consists of a carbohydrate attached covalently to reactive groups at the surface of the bulls material, either directly or via functional groups of an oligofunctional compound, said oligofunctional compound in turn having functional groups being capable of reacting with said reactive groups at the surface of the bulk material and with the carbohydrate, wherein said reactive groups are either inherently (a priori) present in the bulk material or wherein said reactive groups have been attached to the surface of the bulls material by a plasma surface preparation, as hereinbefore defined, as well as to a process of manufacture of such a composite material.
The bulls material may be e.g. any material conventionally used for the manufacture of biomedical devices, e.g. contact lenses, which are not hydrophilic per se.
Such materials are known to the skilled artisan and may comprise for example polysiloxanes, fluorinated (meth)acrylates or equivalent fluorinated comonomers derived e.g. from other polymerizable carboxylic acids, alkyl (meth)acrylates or equivalent alkyl comonomers derived from other polymerizable carboxylic acids, or fluorinated polyolefines, such as fluorinated ethylene propylene, or tetrafluoroethylene, preferably in combination with specific dioxols, such as perfluoro-2,2-dimethyl-1,3-dioxol. Examples of suitable bulls materials are e.g. Neofocon, Pasifocon, Telefocon, Silafocon, Fluorsilfocon, Paflufocon, TM iM -Silafocon, Elastofilcon, Fluorofocon or Teflon AF materials, such as Teflon ~1F 1600 or TM
Teflon AF 2400 which are copolymers of about 63 to 73 mol % of perfluoro-2,2-dimethyl-1,3-dioxol and about 37 to 27 mol % of tetrafluoroethylene, or of about 80 to 90 mol % of perfluoro-2,2-dimethyl-1,3-dioxol and about 20 to 10 mol % of tetrafluoroethylene.
The bulls material may also be e.g. any material conventionally used for the manufacture of biomedical devices, e.g. contact lenses, which are hydrophilic per se, since reactive groups, e.g. amine or hydroxy groups are inherently present in the bulk material and therefore also at the surface of a biomedical device manufactured therefrom.
Such WO 94/06485 ~ PCT/PP93/02420 _ materials are known to the skilled artisan. Typical examples comprise e.g.
Polymacon, Tefilcon, ll~tethafilcon, Deltafxlcon, Bu~lcon, Phemfilcon, Ocufilcon, Focofilcon, Etafilcon, ~Iefilcon, Yifilcon, Tetrafileon, PerF~lcon, Droxifilcon, Dimefilcor, Isofilcon, Mafilcon or Atlafilcon. Most of these materials are I~EMA based, but suitable materials may also be based on other underlying monomers or polymers having z~active groups, e.g.
hydroxy groups or amino groups, such as e.g. polyvinyl alcohol.
The bulls material may be any blood-contacting material conventionally used far the manufacture of renal dialysis membranes, blood storage bags, pacemaker leads or vascular grafts. For example, the bulk material may be a polyurethane, polydirnethylsiloxane, polytetrafluoroethylene, polyvinylchloride or DacronTM.
a Moreover, the bulk material may also be an inorganic or metallic base material with or without suitable reactive groups, e.g. ceramic, quartz, or metals, such as geld, or other polymeric or non-polymeric substrates. E.g. for implantable biomedical applications, ceramics, preferably coated with a polysaccharide, are very useful. In addition, e.g. for biosensor purposes, dextran coated base materials are expected to reduce nonspecific binding effects if the structure of the coating is well controlled. Biosensors may require polysaccharides on gold; quartz, or other non-polymeric substrates.
7Che reactive groups, inherently (a priori) present at the surface of the bulk material or having been introduced or attached. to the surface of the bulk material by a plasma surface preparation; as hereia~before defined, may be selected from a wide variety of groups~well known tc~ the skilled artisan. Typical'examples are e:g: hydroxy groups, amine groups, carboxy groups, carbonyl groups, aldehyde groups; sulfonic acid groups, sulfonyl chloride groups, groups being replaceable by amin~ or hydroxy groups, such as halo groups, or mixtures thereof Amino groups and hydroxy groups are preferred.
Suitable organic or inorganic compounds far the plasma surface preparation step are e.g.
ar~imonia, water vapor, carbon dioxide, carbon monoxide, noble gases, e.g.
argon, oxygen, ozone or air, alcohals, amines'or alkanones; preferably lower alkanols having up to eight carbon atoms; lower allcyl amines having up to eight carbon atoms, or lower alkanones having up to eight carbon atoms, e.g. methanol, ethanol, ammonia, methylamine, ethylamine, heptylamine, or acetone; ox many other compounds known to those skilled in the art of plasma surface preparation. It is also within the scope of this invention to use mixtures of the compounds mentioned hereinbefore.
The first step of deposition of plasma polymer thin film coatings containing on their surfaces reactive ~rou~s such as amine and hydroxyl groups is fully described in WO 89/11500 (Griesser et al.) and in Griesser H.J. and Chatelier It.C. Journal of Applied Polymer Science: Applied Polymer Symposium 46, 361-384 (1990);
Suitable activating compounds for the optional step 2 are e.g. anhydrides or activated esters, such as 2,2,2-trifluoroethanesulphonyl chloride, p-toluenesulphonyl chloride, cyanogen bromide or p-nitrophenylesters.
Suitable oligofunctional compounds for the optional step 2 have preferably up to four functional groups and are, more preferred, bifunctional. Preferred bifunctional compounds for step 2 are preferably epihalohydrins, bis-oxiranes or diisocyanates.
Typical examples are e.g. the diglycidyl ether of bisphenol A, 1,3-butadiene diepoxide or the diglycidyl ether of 1,4-butanediol. These bifunctional compounds yield an activated surface with pendant epoxy groups, halogen groups or isocyanato groups. However, the present invention is not limited to the use of epoxy, halogen or isocyanato groups as functional groups. Many other oligo- or bifunctional reactive compounds can effect the desired covalent crosslinking between a reactive group rich coating, e.g. a hydroxyl or amine rich coating; and a carbohydrate. For example, other suitable bifunctional compounds are diacid chlorides, ditosylates, dihydrazides and any compound which contains more than one functional group which can react with the reactive groups as hereinbefore defined. A
preferred embodiment of the invention is the use of epihalohydrins, bis-oxiranes (diglycidyl ethers) or diisocyanates as oligofunctional compounds. It is further preferred that said oligofunctional compounds, or in the preferred case the bifunctional compounds, have different reactivity with respect to their functional groups, or to their two functional groups, respectively.
Suitable epihalohydrins are e.g. epichlorohydrine or methylepichlorohydrin.
One class of bis-oxirane compounds comprises diglycidyl compounds of formula I
\o/ (I) - to -wherein D is an organic divalent radical and wherein each of the glycidyloyxy groups are covalently bonded to a carbon atom of D. Preferably the compounds of formula I
are polyglycidyl ethers or carboxylate esters.
The organic radical D may be aliphatic, heterocyclic, aromatic, or araliphatic which is bound to the glycidyl oxygen directly or through a carbonyl group.
In one preferred embodiment D is aliphatic. Especially suitable radicals include alkylene of up to 25 carbon atoms, or said alkylene interrupted by one or more hetero atoms, such as oxygen, or cyclohexylene.' More preferably, D is alkylene of 2 to 6 carbon atoms, or _CZ:.C4_~y~ene(Q-C2-C4-alkylene)p where p is 1 to 8. Also especially suitable are the aforementioned aliphatic radicals terminating in carbonyl groups to form the corresponding diglycidyl carboxylate ester.
In anothLrpreferred embodiment D is aromatic. Especially suitable aromatic radicals itnclude phenyl, biphenyl; phenyl-lower allcylene-phenyl, phenyloxyphenyl, or phenylsulfonylphenyl, which are further unsubstituted or are substituted by lower alkyl, lower allcoxy; or halo:
The term "lower", whenever used in the context of this invention and if not defined otherwise, defines groups having up to seven carbon atoms; preferably groups having up to four carbon atoms: Thus; for the reason of illustration; e.g. lower alkyl is alkyl having up'to 7 carbon atom, such'as methyl, ethyl; propyl; butyl; or hexyl, and lower alkoxy is allcoxy having up to 7 carbon atcims, such as methoxy, ethaxy, butoxy, or heptyloxy.
Another class of bis-oxirane compounds comprises polyglycidyl compounds of the formula ~
~o~ ~I>
wherein E is an organic divalent radical and wherein each of the glycidyl radicals aa~e covalently bonded to a nitrogen er carbon atom of E. Preferably E is aliphatic, aromatic, heterocyclic or araliphatic, as hereinbefore defined for radical D.
v~~ 9~ios4ss ~criE~~ioa~zo ~ -~ ~ :a J ..3. (J id - -In a preferred subembodiment E is a bivalent hydantoin radical which is bound to the glycidyl groups through the respective nuclear nitrogen atoms, and said hydantoin is otherwise unsubstituted or substituted by lower alkyl.
In an alternate preferred subembodiment E is alkylene of up to 6 carbon atoms.
A third class of bis-oxirane compounds are those of the formula III
C\ / "~R2 ~ ~"-c"2 ( ) ~ ~ f ~1 wherein m is 0, 1 or 2 and each R independently represents hydrogen or lower alkyl.
Also mixtures of the above bis-oxiranes of formulae I, II and III may be employed.
Suitable bis-oxiranes, most of which are readily available and all of which are known, and which can be used according to this invention; have been disclosed e.g. in US
patent 4,59$,122.
Suitable bis-oxiranes are e.g. the diglycidyl ether of bisphenol A, 1,3-butadiene diepoxide or the diglycidyl ether of 14-butanediol, divinylbenzene dnoxide, diglycidyl ether, limonene dioxide, vinylcyclohexene dioxide, the diglycidyl ether of bisphenol F, 3;4-epoxycyclohexylmethyl 3,4~epoxy-cyclohexane carbo~cylate, phthalic acid digl~cidyl ester, diglycidyl atniline, or oligoethyleneoxide diclycidylethers; such as di(ethyleneglycol) diglydicyl ether, tetra(ethyleneglycol) diglycidyl ether, or octa(ethyleneglycol) diglycidyl ether.
Suitable diisocyanates are generally aromatic; aliphatic or cycloaliphatic diisocyanates, or mixtures thereof. The aromatic moiety thereof is preferably phenyl, naphthyl or anthryl, which are unsubstituted or substituted by alkyl having up,to four carbon atoms, by alkoxy having up to four carbon atoms or by halo; preferably chloro, wherein twa aromatic anoieties may be connected by an ether bond or by an allcenylene group of up to four carbon atoms; the aliphatic moiety thereof is preferably alkyl having up to 10 carbon atoms; the cycloaliphatic gnoiety thereof is preferably cycloalkyl or bicycloalkyl having up to 6 carbon atoms in each cyclc~alkyl ring.
,, . ~ r:., .t.,.::
.S!.::~.'.~~. .. :~. ,~.~.... . . ~ '.. .~:.',;. .. 'i. :.~.: . .,.,. ~ -~,..
:.:..,~.. ,..:~...~. ., ~ .'.. , . .:'.. ,.;...." ".~.; ::.:
v n.... ~ ..............,,"".. .. .............,s..... . . , . .... . . ' ' . -...., . , , W~ 94/06485 PCT/EP93/02420 2~~~~~~
Examples of such diisocyanates are toluene-2,4-diisocyanate, toluene-2,6-diisocyanate, isophorone diisocyanate, ethylene diisacyanate, ethylidene diisocyanate, propylene-1,2-di-isocyanate, cyclohexylene-I,2-diisocyanate, cyclohexylene-1,4-diisocyanate, m-phenyle-ne-1,2-diisocyanate, 3,3'-diphenyl-4,4'-biphenylene diisocyanate, 4,4'-biphenylene diiso-cyanate, 4,4'-diphenylmethane diisocyanate, 3,3'-dichloro-4,4'-biphenylene diisocyanate, 4,4'-diphenyl diisocyanate, I,6-hexamethylene diisocyanate, 2,2,4-trimethyl-hexamethyle-ne diisocyanate, 1,4-tetramethylene diisocyanate, 1,10-decamethylene diisocyanate, cume-ne-2,4-diisocyanate, 1,5-naphthalene diisocyanate, methylene dicyclohexyl diisocyanate, 1,4-cyclohexylene diisocyanate, p-tetramethyl xylylene diisocyanate, p-phenylene-1,4-di-isocyanate, 4-methoxy-1,3~phenylene diisacyanate, 4-chloro-1,3-phenylene diisocyanate, 4-bromo-l,3-phenylene diisocyanate, 4-ethoxy-1,3-phenylene diisocyanate, 2,4-dimethyl-1,3-phenylene diisocyanate, 5,6-dimethyl-1,3-phenylene diisacyanate, 2,4-diisacyanatodi-phenylether, 4,4'-diisocyanatodiphenylether, benzidine diisocyanate, 4,6-dimethyl-1,3-phenylene dii5ocyanate, 9,10-anthracene diisocyanate, 4,4'-diisocyanatadibenzyl, 3,3'-di-methyl-4,4'-diisocyanatodiphenylmethane, 2,6-dimethyl-4,4'-diisocyanatodiphenyl, 2,4-di-isocyanatostilbene, 3,3'-dimethoxy~-4.,4'-diisocyanatodiphenyl, I,4-anthracene diiso-cyanate, 1;8-naphthalene diisocyanate, 1,3-bis-isocyanatomethyl-cyclohexane, or 4,4'-(dicyclohexyl)methane dvsocyanate.
Preferred are diisocyanates having different reactivity with respect to their two NCO
groups, such as isophorone diisocyanate; 2;4-toluene diisocyanate, or 2;2,4-trimethylhexamethylene diisocyanate.
Suitable carbohydrates according to this invention comprise natural products, modified carbohydrates and syntJhetic earbohydrates:'Examples far these groups of carbohydrates are sugars; such as monosaccharides; di- and oligosaccharides, cyclic oligosaccharides, linear polysaccharides, whether homopolysaccharides or heteropolysaccharides, branched polysaccharides, segment~,,d polysaccharides, lipopolysaccharides, glycoproteins and proteoglycans. The modified products or synthetic products may be modified e.g. by oxidation, ether~cation or esterification, they may further comprise functional groups such as aldehyde groups, acetal groups, ketal groups, acylamino groups, preferably acetylarryino groups, anhydro groups or lactone groups. They may fuzther have groups which niay be charged, sa~ch as -NH2, -COOH, -OS03H, or -OP(O)(OH)2.
Examples of suitable carbohydrates are known to the skilled artisan and can be found in W~ 94/Ob4~5 PCT/EP93/02420 conventional textbooks, or monographs. The following listing is exemplary only and not meant to restrict the invention:
Suitable sugars are e.g. glucosamin; galaktasamin, neuraminic acid, muraminic acid, sialinic acid, L-fucose, arabinose, xylose, glucuronic acid, gluconic acid or levoglucosan.
Suitable oligosaccarides are e:g: lactose, maltose, cellobiose, chitohexanose, trehalose, isomaltulose, leucrose.
Suitable polysacch~rrides and derivatives are e.g, hyaluronic acid, deacylated hyaluronic acid, chitosan, chitin 5Q, fucoidan, carrageenans, dextran, bhze dextran, aminated dextran, galaktomannian, glueomannan, pullulan, glycosaminoglycan, heparin, agarose, curdlan, pectin, pectic acid, xanthan, hydroxypropyl cellulose or chitosan, carboxymethyl cellulose or chitosan, emulsan, laminaran, inulin, pustulan, scleroglucan, schi2ophyllan, or mucopolysaccharides.
Further examples of suitable carbohydrates are D-ribose, L-arabinose, D-xylose, L-fucose, D-mannose, D-galactose; I?-glucosamine; muramic acid, D-galactosamine; D-gluocoronic acid, D-mannuronic acid, D-galacturonic acid,' L-glycero-D-manno-heptose, neuraminic acid. Further examples o~ polysaccharides are agarose, alginates, carea.geenan, cellulosics, such as acetate; carboxymethyl,'ethyl; hydroxyethyl, hydr~xypropyl, hydi-oxypropylmethyl, methyl cellulose, chitin / chitosan, dextran, furcellaran, gellan gum, guar gum; guts arabic, heparin, hyaluronic acid, hydroxypropyl guar, karaya gum, laminaran, locust bean gum; pectin (low or high methoxyi), rhamsan gum, starches, iragacant guru; welan gum; xanthan gum.
Examples of especially suitable xnonosaccharides include glycerol, threose, glucose, galactose and fructose. Examples of especially suitable ~ligosaecharides include sucrose, maltose, lactose arid cellobiose. Examples of especially suitable polysaccharides include dextrans; starches, dextrins; glycogens; inulin; glycosaminoglycans and mucopolysaccharides; further preferred are dextran, chitosan, hyaluronic acid, mucin, fucoidan; and gl~acosamin.
naturally occurring carbohydrates nnay be modified in order to enhance their reactivity with acravated surfaces. For example, oxidation of dextran with periodate yields aldehydes which can react with amines on the surface of the material; treatment of dextran with 2122~~
bromoacetic acid in alkaline solution places pendant carboxymethyl groups on the polysaccharide backbone which, in turn, can form ester or amide links with surface hydroxyls or amines, respectively; treatment of dextran with choroethylamine in alkaline solution places pendant aminomethyl groups on the polysaccharide backbone which, in turn, can react with surface 'epoxy, acid chloride or tosylate groups.
Step two may be performed by immersing the plasma treated material in a solution or vapour of oligo- or bifunctional compound. For example, the surface may be immersed in a solution of 0:1-5.0 ml epichlorohydrin (preferably 0.2-2.0 ml), and 10-100 ml of 0.4 ml of 0.4 M sodium hydroxide (preferably 20-30 ml} in 10-100 ml of diethyIene glycol dimethyl ether (preferably 20-30 m1) for 1-6 hours (preferably 4-6 hours) at 10-60°C
(preferably 20-30°C). Alternatively, the surface may be immersed in a solution containing 20 ml water, 0.4 ml 1,4-butanediol diglycidylether; and 1 ml benzyltrimethylammonium hydroxide at f0°C for 5 hours. The sample is then rinsed with water at room temperature.
The reaction between the carbohydrate and the reactive groups of the surface is performed in such a way that a highly water retaining carbohydrate layer is provided on the outermost surface of the novel composite material. Preferably the material with an activated surface is placed in a solution of carbohydrate for an appropriate time. For example the method described by S: Lofas and B. Johnsson in J. Chem. Soc.:
Chem.
Commun. 1526 (1990) may be used. Thus the surface can be reacted with 0.1-I5.0 g (preferably 2.0-5.0 g) of dextran (molecular weight 1,000-S,OOO;OOO Da;
preferably 500;000-2;000,000 Da) ins 1.0-50 ml (preferably 20-30 ml} of 0:01-5.0 M
(preferably 0.1-2.0 M) sodium hydroxide for 0.1-48 hours (preferably 20-25 hours) at IO-60°C
(preferably 20-30°C)~ Excess dextran is washed off by rinsing the sample in distilled water. Alternatively, the material may be immersed in a solution containing 20 ml water, 0.2 g dextran (molecular weight 1;000 to 40;000,000 Da (preferably 500,000 to 40,000,000 Da} and l ml benzyltrimethylamrnonium hydroxide at 60°C far 18 hours.
Again, excess dextran is washed off by rinsing the sample in distilled water.
The invention encompasses all such methods and the biomedical devices, e.g.
ophthalmic devices so obtained.
The biomedical: devices of the inventions are e:g. implantable biomedical devices, such as prostheses; vascular grafts, catheters, pacemakers or shunts, or ophthalmic devices. The ophthalmic device of the invention is e:g. a contact lens, an eye bandage or an intraocular . f .~~.~ ... ~': .'. .f., .
.7 . , J .
'. ( .
h ,..:
~~ S~
' t /'.t.~'y a. .
1a m ., .... . , . u. ;'.'.k _, ...m. . . _, . '.A"w.,.
.,.,n. .,.1;', v.... , ..1...... . ,.... I ..a . . .;.fir..,, i'fO 94106355 PCf/EP93/02420 2~.2~v~~
Lens, and preferably it is a contact lens.
In its broadest aspects the invention is directed to a composite material, especially a biomeclical device, e.g. an ophthalmic device, preferably a contact lens, with one or more, preferably one or two, wettable surfaces capable of holding a continous Iayer of aqueous fluid thereon which composite material comprises a bulk material and a hydrophilic coating characterized in that the hydrophilic coating consists of a carbohydrate, including a modified carbohydrate, attached covalently to reactive groups at the surface of the bulk material, either directly or via functional groups of an oligofunctional compound, said oligofunctional compound in turn having functional groups being capable of reacting with said reactive groups at the surface of the bulk material and with the carbohydrate, wherein said reactive groups are either inherently (a priori) present in the bulk material or wherein said reactive groups have been attached to the surface of the bulk material by a plasma surface preparation.
A, preferred subembodiment of the invention is a biomedical device, e.g. an ophthalmic device wherein reactive groups are inherently present in the bulk material and wherein the oligofunctional compound is a bis-oxirane or an epihalohydrin; preferably a bis-oxirane.
A further:preferred subembodiment of the invention is a biomedical device, e.g. an ophthalmic device wherein reactive groups are inherently present in the bulk material, wherein the oligofunctional compound is a bis-oxirane and the carbohydrate is a polysaccharide: Said carbohydrate is preferably selected from dextran, chitosan, hyaluronic acid, mucin; fucoidan; and ghcosamin.
A f~er preferred subembodiment of the invention is a biomedical device, e.g.
an ophthalmic device wherein reactive groups are inherently present in the bulk material, wherein he c~Iigofur~ctional compound is a diisocyanate and the carbohydrate is a non-polysaccharide carbohydrate.
A further preferred subembodiment of the izwention is a biomedical device, e.g: an ophthalmic device wherein reactive groups are inherently present in the bulk material, wherein the oligofunetional compound is a diisoeyanate and the carbohydrate is dextran.
An additionally preferred subembodiment of the invention is a biomedical device, e.g. an ophthalmic device wherein reactive groups are inherently present in the bulk material, and 2~.~~3~~
wherein the oligofunctional compound has different reactivity with respect to its functional groups. Such ~n oligofunctional compound may be e.g. a bis-oxirane.having different reactivity with respect to its two functional groups, such as for example limonene dioxide, vinylcyclohexene dioxide; 3,4-epoxycyclohexylmethyl 3,4-epoxy-cyclohexane carboxylate, or it maybe e.g. a diisocyanate having different reactivity with respect to its two functional groups, such as for example isophorone diisocyanate, 2,4-toluene diisocyanate, or 2,2,4-trimethylhexamethylene diisocyanate.
Another preferred embodiment of the invention is a biomedical device, e.g. an ophthalmic device wherein said reactive groups have been attached to said surface by a plasma surface preparation and wherein the oligofuncdonal compound is selected from an epihalohydrin, bis-oxirane; diisocyanate, diacid chloride, and ditosylate.
Within this embodiment it is preferred that the oligofunctional compound is a bis-oxirane.
It is further preferred that the oligofunctional compound is a bis-oxirane having different reactivity with respect to its two: functional groups:
Another preferred embodiment of the invention is a biomedical device, e.g. an ophthalmic device wherein said reactive groups have been attached to said surface by a plasma s~a~ preparation and wherein the oligofunctional compound is a bis-oxirane and the carbohydrate is a polysaccharide; which is preferably selected from dextran;
chitosan, hyaluronic acid, mucin, fucoidan, and glucosamin:
Another preferred embodiment of the invention is a biomedical device, e.g. an ophthalmic device wherein said reaotive groups have been attached to said surface by a plasma surface preparation and wherein the oligofunctional compound is a diisocyanate. It is further preferred that the oligofunctional compound is a diisocyanate having different reactivity with respect to its two functional groups.
Another preferred embodiment of the invention is a biomedical device, e.g. an ophthalmic device wherein said reactive groups have 'peen attached to said surface by a plasma surface preparation and wherein the oligofunctional compound is a diisocyanate and the carbohydrate is a polysaccharide; which is preferably selected from dextran, chitosan, hyaluronic acid; mucin, fucoidan; and glucosamin.
A further-preferred subembodiment of the invention is a biomedical device, e.g. an ophthalmic device wherein reactive groups are inherently present in the bulk material, wherein the carbohydrate is a polysaccharide which is directly bonded to the reactive groups. Said carbohydrate is preferably selected from dextran, chitosan, hyaluronic acid, mucin, fucoidan, and glucosamin.
A further preferred subembodiment of the invention is a biomedical device, e.g. an ophthalmic device wherein reactive groups are inherently present in the bulls material, wherein the carbohydrate is a non-polysaccharide carbohydrate which is directly bonded to the reactive groups.
A further preferred subembodinnentof the invention is a biomedical device, e.g. an ophthalmic device wherein'reactive groups are inherently present in the bulk material, wherein the carbohydrate is dextran which is directly bonded to the reactive groups.
Another preferred embodiment of the invention is a biomedicai device, e.g. an.
ophthalmic device wherein said reactive groups have been attached to said surface by a plasma surface preparation and wherein the carbohydrate is a polysaccharide, which is dixecdy bonded o the reactive groups. Said carbohydrate is preferably selected from dextran, I
chitosan, hyaluronic acid, mucin; fucoidan, and glucosamin.
Another preferred embodiment of the invention is a biomedical device, e.g. an ophthalmic device wherein said reactive groups which have been attached to said surface by a plasma surface preparation are hydroxy or amino groups and wherein the carbohydrate which is directly bonded to the reactive groups is preferably selected from dextran, ehitosan, hyaluronic acid, mucin, fucoidanand glucosamin, and is most preferably dextran.
The biomedical devices, e:g. ophthalmic devices according to the present invention have a variety of unexpected advances over those of the' prior art- which make those devices, especially contact lenses, according to the invention very suitable for practical purposes, e.gas contact lenses for extended wean For example, they do have a high surface wettability which can be demonstrated by their contact angles, their water retention and their water-film break up time or tear film break up time. The water retention time is closely related to the water-film break up time ("gUT°') and the tear film break up time, in that a high water retention time results in a high water-film break up time or tear film break up time.
WO 94!06485 ~ PCT/EP93I02420 ~"w"~a:
212~3~~
_ Ig _ In addition the biomedical devices; e.g. ophthalmic devices, such as contact lenses according to this invention have a very pronounced biocompatibility combined with good mechanical properties. For example, there are generally no adverse eye effects observed, while the adsorption of proteins or lipids is low, also salt deposit formation is lower than with conventional contact lenses. Generally one may state that there is low fouling, low microbial adhesion and low bioerosion while the good mechanical properties can be for example found in a low friction coefficient and low abrasion properties.
In summary the ophthalmic devices according to this invention, such as contact lenses, provide a combination of low spoilation with respect to cell debris, cosmetics, dust or dirt, solvent vapors or chemicals, with a high comfort for the patient wearing such contact lenses in view of the soft hydrogel surface which for example provides a very good on-eye movement of the contact lenses:
t :."
: ".~, : ~:s. ~.'.
.:, ;fi . r ....:J~.., .?...r A
1 5:
.. l .... '~o,pp.
.1~.'.. .. ) .G. a k..
., it. .
..r. . r.. .Y.,...r ...
a... t......r . .1:.:~.~.~, .. .. .. .. .n....tv: . , . . . ...n..v. ,.. .. .
.. .. «~:~'!. .. .. , .. , ....
'1~V~ 94/0645 P~'/EI'~3/02420 (CI-)-NH..--CH~.CH-CH2 --O ' , ~ ~ O--CHZ-CH-CH2 CH3 or H
Scheme II
;, (CL) - OH + C~~--CH.-CH2.~._CI --s' (CL) - O--CH2-C~. ~ H2 O O
wherein (CL) denotes the surface of a contact lens, (CL)-NH2 denotes an exemplary amino group present at the surface of said contact lens and (CL}-OH denotes an exemplary hydroxy group present at the surface of Said Contact Iens.
A further reaction scheme shows the covalent attachment of a carbohydrate onto epoxy groups bonded to a biomedical device, e:g. a contact lens:
Scheme IZI
R ~ ~O- CH2 H ~ 0 H
(CL) - O-.-GH2.---CH-CHI + pF~i H -_-~~ Hp~ p-R2 'fH'''' OH °
R~-O- CHz H H O H
(~~) _ O.--CH2-CH-CH2---O ~H H ~_R2 ~' H ()H
OH
vyherein (CL} denotes the surface of a contact lens, and F~.~ and R2 have the meaning of a conventional residue extending the chain of a carbohydrate.
Where the carbohyd~~ate contains a traps vicinal diol the carbohydrate, such as e.g.
dextran, may be oxidized in part with an appropriate oxidizing agent, e.g.
with sodium periadate, in order to obtain ring cleavage and formation of aldehyde functions. Said WO 94/(Dfi48S PCT/EP93/02420 -2a-aldehyde functions may be reacted with amino groups, present as reactive groups or as functional groups at the surface of the biomedical device, to form an -N=CI3-group. Said groups may be reduced with a suitable reducing agent to a hydrolytically stable -I'~H-CH2-group linking the carbohydrate molecule to the device surface.
Without limiting the invention, further combinations of chemical groups which may be reacted with each other in order to obtain composite materials according to this invention are e.g. as follows: A carbonyl reactive group at the surface of the device is reacted with a hydrazide functional group of a dihydrazade while the other hydrazide functional group thereof is reacted with an aldehyde group of a carbohydrate. An aldehyde reactive group at the surface of the device is reacted with an amino group of a carbohydrate, and reduced if desired. An amino reactive group or a hydroxy reactive group at the surface of the device is reacted with an epoxide functional group of a diepoxide while the other epoxide functional group thereof is reacted with an amino or hydroxy group of a carbohydrate. An amino reactive group or a hydroxy reactive group at the surface of the device is reacted with one functional end group of an epichlorohydrin while the other functional end group thereof is reacted with an amino or hydroxy group of a carbohydrate. An amino reactive group or a hydroxy reactive group at the surface of the device is reacted with an isocyanato functional group of a diisocyanate while the other isocyanato functional group thereof is reacted with an amino or hydroxy group~of a carbohydrate. A carboxy group at the surface of the device is reacted with an amino group of a carbohydrate. A
reactive gr~up at he surface of the device which is replaceable by an amino yr hydroxy group is replaced by an amino or hydroxy group of a carbohydrate. s In the examples, if not otherwise indicated; temperatures are given in degrees Celsius, and contact angles are given in degrees.
Example 1 (Comparative): Commercially available fluoropolymer (Fluorofocon ATM) contact lenses are'rerr~oved from storage in saline solution, rinsed with distilled water and inserted for in vivo testing (with unpreserved, buffered saline Solution).
Each lens is fitted tb a subject who is unadapted to contact lens wear. Subjects are chosen to whom the lenses could be adequately fitted The measured variables are: (1) overall wettability, (2) front surface break up time (FS BU'T); (3)' speed of surface drying, (4) surface coverage. The variables are assessed immediately after insertion and again ten minutes after insertion.
Example 2 (Comparative): C~mmercially available silicone elastomer (Elastofilcon ~~ ~~J~~J
ATM) contact lenses are removed from storage in saline solution, rinsed with distilled water and then allowed to dry in air prior to measurement of air/water contact angles.
Contact angles are measu~ned using a modified Kernco-G2 contact angle goniometer. By placing the sample on a flat stage and placing a drop of distilled water on the apex of the anterior lens surface usin ~ micrometer driven s 'n e, and then ali 'n rotatable cross g Yn g ~ g hairs in the eyepiece at a tangent to the cazrvature of the lens and the drop at the water/air/lens interface, the sessile contact angle (SCA) can be measured. The micrometer driven syringe is then used tea gradually increase the volume of the drop by injecting more water into it, just until the drop begins to advance across the surface, at which point the advancing contact angle (ACA) is measured using the rotatable crosshairs. The micrometer driven syringe is then used to gradually decrease the volume of the drop by withdrawing water from it, until the drop begins to recede across the surface, at which point the receding contact angle (RCA) is measured.
Exam 1e 3: Commercial) avaiiable'RGP fluoro of er luorofocon ATM
P Y P Ym ~ ) contact lenses are coated with a thin polymer film produced by plasma polymerization of methanol vapour at a pressure of 0.7 torn, ihput power of 10 watts, signal frequency of 300 kHz and treatment time of l minute:
The plasma modified contact lenses are reacted with 0.235 ml of epichlorohydrin in a mixture of 25 mI 'of 0.4 M Na~H and 25 ml of diethylene glycol dimethyl ether at 20°C
for 4 hours. The lenses are then washed 3 times in distillecl water, twice with ethanol and again 3 times in distilled water.
Dexaan is attached to the ~pichlorhydrin treated lens surfaces by soaking in a solution of 3:0 g Dextran dissolved in 25 ml of 0:1 M NaOH for 20 hours. The lenses are then washed times in distilled water and allowed to dry in air before measuring contact angles. The treated lenses are then stored in saline solution before testing under identical conditions as example 1 The in vitro data in Table 1 reveal a decrease in sessile, advancing and receding air/water contact angles of the contact lenses when the surfaces are treated according to this invention.
The in vivo data in Table 2-reveal an increase in wettability by tear film when the surfaces ~:~ ~ Y '. S n ,.r . A .- , ."... .; , ~a: . . ~ : : ~~ i~. ;',~ .,', ,,.;',. ~ ..~~ ... ~,..:. . n...
...: ~ r. ;~.: . , ~. ~ .; -...' , -.,~:, ,. .'~. . "o :~.. ~ ~.'. ,.
,.......-,. ... .. ._...:,, ..,.,;~:v'..y, .;...,.,.. .'.'1'; ~....._..,, ..~:.;:,~,., ',~....':' . : .".':.-. ~ .'..::,.;.,,. .,. :°,'. .~...:.y ,.,,...:: , ;.....,.:_..., VV~ 94/06485 PCT/EP93/0?~t20 ~~~~J~~ sin";
are treated according to this invention.
Example 4: Example 4 is identical to Example 3, except that the contact lenses are commercially available silicone elastomer (Elastofilcon ATM) contact lenses, and measurements of air/water contact angles are made after rinsing with distilled water and allowed to dry in air. The results in ''fable 1 reveal a decrease in sessile, advancing and receding air/water contact angles of the contact lenses when the surfaces are treated aGCOrdlng t0 thlS inYentlOn.
Brief description of Tables 1 and 2 Table 1 shows the change in air/water contact angles consetluent on attachment of polysaccharide onto the surface of RGP fluoropolymer (Fluorofocon ATM) and silicone elastomer (Elastofilcon ATM) contact lenses.
Tabls 2 shows the effect of grafted polysaccharide on the time taken for the contact lens to dry; for RGP fluoropolymer (Fluorofocon ATM) contact lenses.
Table 1 Contact L.~ns~ SCA* ~,CA*RCA*
Fluorofocon ATM lenses:
Untreated lenses 111 119 47 Lenses with lDextran MW = 500;000 90 95 9 Lenses with Dextran M'~ = 2'000 80 85 4 Elastoftlcon ATM lenses:
iUntreated lenses x 107 61 tenses with Dextrin (M'W .= 500,000)99 104 45 Lenses with Dextran (MW - 2'000,000)93 99 17 * SCA;
ACA and RCA are the sessile, advancing and receding air/water contact azagles respectively.
WO 94/064$5 PGT/EP93/02420 ?1?~'a~~
Table 2 Variable ~ti~y After 10 minutes Example ComparativeExample Comparative exare~ple example Wettabilit 3.5 +/- 2:5 +/ 1:3 3.3 +/- 1.9 +/-* 0.9 0.6 0.7 FS BUT# (sees)10 +/: 7 +/ 4 9 +/ 2 S +/- 2 Speed of drying+1.4 +/- 2:1 +/ 0.7 1.3 +/- 2:9 +/-- 0.6 0:4 0.2 ~' Wenabitity 0 = surface completely non-wetting I -- very thin tear layer, fast break up time (BUT) 2 = moderately thin layer;
fast BUT
3 = tear layer slightly thin, BUT approximately equal to interblink interval 4 = tear Iayer thick and smooth, no dry patches, BUT greater than interblinlc interval #FSBUT
Front surface break up time' + Speed of drying 1='slow 2 = moderate 3 = fast Exatnpte.'S
(Comparison):
An important criterion for the usefulness of the present t.
a invention is the dme taken for water to recede from 50 % of the surface of a substrate;
such-as a contact lens:
This parameter is' abbreviated' "WRT"' and presented in secomds in this example and hereinafter, The bulls material used is fluorinated ethylene propylene.
This material, without modification of its surface has a WRT of < 1 second.
Example 6: A flat substrate of fluorinated ethylene propylene is subjected to a plasma treatment'in the presence of heptylamane.
I g of polysaccharide in 200 ml water is treated with 3 g NaI44 and, reacted with the plasma treated ubstrate having amino groups at its surface in the presence of NaCNBH3 at a pH
of 6 to 9. A substrate with a hydrophilic coating is obtained for which the following time taken for water to recede from SO
% of the urface (WRT) is'measured:
polysaccharide MW WRT
(kDa) (see) wo ~aeo6ass Pcre~~93eo2aao 2~.2~~~~
a) ~ dextran 9.3 180 b) dextran 74.2 180 c) dextran 515. 180 d) dextran 2000 180 e) blue dextrain 2000 180 f) pectic acid n.d. 180 g} polyquat JR30M n.d. 90 Example 7: A flat substrate of fluorinated ethylene propylene is subjected to a plasma treatment in the presence of methanol: 7:'he substrate having hydroxy groups at its surface is treated with 1,4-butanediol diglycidyl ether in the presence of benzyltrimettaylammo-nium hydroxide and with dextran. A substrate with a hydrophilic coating is obtained fox which the following tune taken foz~ water to recede from 50 % of the surface (WRT) is measured:
polysaccharide M~ WRT
(kDa) (sec) a} dextran - 515 75 b) dextranu 2000 90 dextran 2000 210 d) dextran ~-40000 >300 .
In the f~llowing examples 1,4-butanetiiol diglycidyl ether is replaced by di(ethyleneglycol)diglycidyl ethsr (example e), by tetra(ethyleneglycol)diglycidyl ether (example f) or by octa(ethylene~Iycol)diglycidyl ether (example g):
e) ' dextran 2000 150 dextran 20t~0 90 g} dextran 2000 13S
example 8; An Elastofilcon contact lens is subjected to a plasma treatment in the presence of heptylamine. Dextran with a molecular weight (MVi~ of 74.2 kDa is treated with NaIOq/NaChIBH3 and reacted with the plasma treated contact lens having amino groups at its surface. A contact lens with a hydrophilic coating is obtained for which a time taken for water to recede from 5'0 % of the surface (WRT) of 180 seconds is measured.
Example 9: A Tefilcon contact lens is subjected to a plasma treatment in the presence of heptylamine. Dextran with a molecular weight (MW) of 74.2 kDa is treated with NaI04/NaCNBH3 and reacted with the plasma treated contact lens having amino groups at its surface. A contact lens with a hydrophilic coating is obtained for which a time taken for water to recede from 50 % of the surface (WRT) of 90 seconds is measured.
By contrast, a Tefilcon contact lens, without modification of its surface, has a WRT of 10 seconds.
TM
Example 10: A flat substrate of a) polyurethane, b) glass and c) Al-Kapton is subjected to a plasma treatment in the presence of heptylamine. A polysaccharide is treated with NaI04/NaCNBH3 and reacted with the plasma treated substrate having amino groups at its surface. A substrate with a hydrophilic coating is obtained for which the following time taken for water to recede from 50 % of the surface (WRT) is measured:
polysaccharide MW WRT
(kDa) (sec) a) dextran 74.2 900 b) dextran 74.2 120 c) dextran 74.2 120 Example 11: A silicone film, made from IJV - cured silicone PS 2067 (Huls America Inc, Bristol, USA) by casting it on a Folanorm foil (Folex ~, Zurich, Switzerland) and irradiation, is placed in an RF-GDP system (radio frequency glow discharge plasma) and the system is evacuated to 0.1 mbar. The film is exposed at a pressure of 0.1 mbar to an oxygen plasma at a power of about 40 W, at an oxygen flow of 10 nanocubic centimeters for 30 seconds, thereafter to air with release of the vacuum.
Example 12: A polybutadiene film, made from a tetrahydrofuran solution of poly(1,2-syndiotactic butadiene) (Polysciences, Inc., cat # 16317) by casting said solution TM
on a Folanorm foil and evaporating the tetrahydrofuran under a nitrogen flow, is modified by the method described in example 11.
WO 94106485 PCf/EP93l02420 2~.2~3~3 -26=
Example 13~ The plasma treated silicone film of example I 1 is placed into a desiccator over about 5 ml of 2,4-tolylene diisocyanate (2,4-TDn. The desiccator is heated to 50°C
and evaCUated to 0.008 mbar: The reaction with 2,4-TDI vapors is carried out for 2.S
hours. After cooling to room temperature the film is taken off, washed vigorously with dry acetone and soaked in a DMSO solution (comprising S % LiCI) of chitosan for 8 hows.
The modified film is washed thereafter 24 hours with water, dried and analyzed.
Examples 14 to I6: The following films are treated according to the method of example 13 except where specified otherwise:
Example 14: The oxygen plasma treated polybutadiene film of example L2. Time of vapor reaction is 2~S hours.
Example 15: A poly(hydroxyethyL methaerylate) (p-HEMA) film made from a solution consisting of HEMA (92 °Jo), ethylene glycol dimethacrylate (5 %) and, as a photoinitiator, Irgacure 184 (3 %) by casting it on a Folanorm foil and UV - irradiation. Time of vapor reaction is 6 hours: Tirne of reaction with chitosan is only 30 minutes.
Example l6: A polyvinyl alcohol' film (PVA) made from a DMSO solution of PVA
(Fluky AG) (99 %) and isophorone diisocyanate (IPDn, (Aldrich) (1 %) by casting it on a Folanorm foil and heating to 70°C for 2 hours under reduced pressure.
Time of vapor reaction is 6 hours. Time of reaction with chitosan is only .~i0 minutes.
The-following table lists the contact angles ("CA"); measured with a system G
40 (Kriiss GmbH, Hamburg Germany), of the polymeric films before treatment and after treatment:
Example Material CA' before CA after treatment (°) treatment (°) 13 silicone 100.4 56.9 14 polybutadiene 79:5 52.5 15 p'-HEMA 78:4 67.5 I6 pVA 47:1 31.5 Examples l7 to 20: Examples 13 to lb' are repeated with the same 2,4-TDI vapor modified films; but using, itrstead of the step of soaking in a chitosan solution, the step of WO 94/06485 ~ PCT/EP93102420 2.~~ZJ~~
_27_ soaking in a 1 % solution of hyaluronic acid, comprising about 1 mg of catalyst (DBTDL), in DMSO. The hyaluronic acid is obtained from Czechoslovakia (Product ZD
Straznice, CSFR).
The following table lists the contact angles ("CA"), measured with a system G
40 (Kruss GmbH; Hamburg Germany), of the polymeric films before tmatment and after treatment:
Example Material CA before CA after ~a~ent (°) treatment (°) 17 silicone 100.4 57.0 I g polybutadiene 79.5 68.0 19 p-HEMA 77:8 58.3 20 PYA 47.1 42.1 Examples 21 to 24: Polymeric films as described in ex:unples 13 to I6 are soaked in a °!0 2,4-TDl solution in a solvent incapable to swell the polymer (for solvent information see table hereinafter): The reactions are carried out at room temperature, under nitrogen gas for 12 hours. Afmr reaction the films are washed in acetone and dried under reduced pressure. The films arse thereafter soaked in a 1 % DMSO solution (comprising 5 °lo LiCI) of chitosan for 24 hours. The modified films are washed thereafter .for 24 hours with distilled water, dried'and analyzed.
The following table lists the contact angles ("CA"), measured with a system G
40 (ICruss GmbH, Hamburg Germany), of the polymeric films before treatment and after treatment:
Example ' Material CA before CA after (Solvent) treatment (°) treatment (°) 2 i silicone I00~4 59.8 (DMSO) 22 polybutadiene 79:5 58.0 (D~sO>
23 p-HEMA ?78 54.0 (tetrahydrofurane and diethylether) wo ~4ro6ass Pcri~rP~3rozazo 24 PVA 47.1 3?.5 (acetonitril) Examples 2S to 27: Examples 22 to 24 are repeated with the same 2,4-TDI
solution modified films, but using, instead of the step of soaking in a chitosan solution, the step of soaking in a 1 % solution of hyaluionic acid, comprising about 1 mg of catalyst (DBTDL), in DMSC?.
The following table lists the contact angles ("CA"), measured with a system G
40 (Kriiss GmbH, Hamburg Germany); of the polymeric films before treatment and after treatment:
Example Material CA before CA after heatment (°) treatment (°) 25 polybutadiene 7~.5 59.1 26 g_HEMA ? 8.0 55.1 27 PVA 48.U 38.0 Example 28: Washed and lyophilized STD TM contact lenses (from CIBA Vision, Atlanta, Tefilcon), based on a crosslinked polymer of p-HEMA; are soaked in a mixture of ml of tetrahydrofurane, 5 ml of diethylether, 0.2 g of isophorone diisocyanate (IPDI) and mg of catalyst (DBTDL)The reaction proceeds at room temperature under nitrogen flow for 12 hours. Thereafter the lenses axe washed with ace,tone~ dried and soaked in a 0.5 % solution of a carbohydrate in DMSO (comprising 5 % LiCI) and (except for example 28 d) D~TDL as a'catatyst. After 1 to 2 hours the lenses are vigorously washed with water, dried and analyzed.
The following table lists the contact angles ("CA"), measured with a system G
40 (I~riiss ' GmbH, Hamburg Germany), of the contact lenses after treatment (for comparison: the contact angle of an untreated STD contact lens is 77 - 78 °):
Example carbohydrate CA after treatment (°) a) Mucin (Sigma) 53.4 b) Fucoidan 50.5 Dextrah . 26.8 VVV9 94/(16485 PG°flEP93/02420 ,~~.<d~~~
d) Glucosamine (Fluke) 38.9 Example 29: Washed and lyophilized EXCELENS Th'1 contact lenses (from CIBA
Vision, Atlanta, Attafilcon), based on a crosslinked polymer of PYA, are soaked in a t mixture of 5 ml of tetrahydrofurane, 5 ml of diethylether, 0.2 g of isophorone ciiisocyanate (IPDI) and 10 mg of catalyst (DBTDL). The reaction proceeds at room temperature under nitrogen for 12 hours. Thereafter the lenses are washed with acetone, dried and soaked in a 0.5 °lo solution of a carbohydrate in D1V1S0 (comprising 5 % LiCI) and (except for example 29 a) DBTDL as a catalyst. After 1 to 2 hours the lenses are vigorously washed with water, dried and analyzed.
The following table lists the contact angles ("CA"), measured with a system G
40 (Krizss GmbH, Hamburg Germany), of the contact lenses after treatment (for comparison:
the contact angle of an untreated EXCELENS contact lens is 69 - 70 °):
Example carbohydrate CA after treatment (°) a) Chitosan 63.1 b) Fucoidan (Sigana) 61.3 c) Dextran (Fluke) 44.9 Exempts 30: A flat substrate of fluorinated ethylene prop;/lene (FEP) or perfluorapolyether(FFPE) is subjected to a plasma treatment in the presence of a) ammonia, b) ~thylenrr diaxnine or c) heptylamine. Dextrari of '74.2 kDa molecular weight is treated with NaIO,q/NaCNBH3 and reacted with the plasma treated substrate having amino groups at its surface: A substrate with a hydrophilic coating is obtained for which the following time taken for water to recede from 50 °lo of the surface (WRT) is measured:
substrate plasma gas WIZT (sec) a) FEP ammonia 160 b) FEP ethylene 160 diamine c) PFPE heptylamine 110 Example 3I: Different contact lenses are subjected to a plasma treatment in the presence ~~.223~~
of ammonia or hept~lamine. Dextran of 74.2 kDa molecular weight is treated with NaIO4lNaCNBH~ and reacted with the plasma treated contact lenses having amino groups at their surface. Contact lenses with a hydrophilic coating are obtained for which the following time taken for water to recede from s0 °lo of the surface (WRT) is measured:
contact lens plasma gas WRT (sec) material
In a econd aspect, the invention provides a biomedical product which provides enhanced comfort to the wearer; whereby said product is composed of a bulls material and a hydrophilic coating according to the first aspect of the invention. The hydrophilic coating consists of a carbohydrate attached co~alently on to a plasma surface prepared on the bulls material, e:g. a thin, fully covering plasma polymer coating.
In a further aspect the invention provides a composite material, especially a biomedical device, e.g. an ophthalmic de~rice; such as a contact lens, with one or more wettable surfaces capable of holding a continuous layer of aqueous fluidthereon characterized in that the composite comprises a carbohydrate which is covalently bound by a hydrolytieally stable bond to reactive gioups inherently present in the bulk material and at the surface of the biomedical device.
According to these aspects of the invention the carbohydrate is hound to the reactive groups either directly or via an oligofunctional compound having one or more functional groups capable of chemically reacting with the said reactive groups and having at least one additional functional group capable of chemically reacting with a carbohydrate to produce an activated surface.
According to on aspect of the present invention, there is provided a composite material having at least one wettable surface capable of holding a continuous layer of aqueous fluid therein, which material comprises: (a) a bulk base material, and (b) a hydrophilic coating, wherein the hydrophilic coating consists of a carbohydrate directly and covalently attached by a hydrolytically stable bond to amino groups at the surface of the bulk base material, wherein said amino groups are either inherently present in the base material or have been attached to the surface of the bulk base material by plasma surface treatment.
According to another aspect of the present invention, there is provided a process for the manufacture of a wettable composite material with at least one wettable surface capable of holding a continuous layer of aqueous fluid thereon, wherein said composite material includes a bulk base material and a hydrophilic coating of a carbohydrate directly attached covalently by a hydrolytically stable bond to amino groups at the at least one wettable surface of the base material, said process comprising the steps of: (1) covalently attaching amino groups onto the at least one wettable surface of a preformed base material by subjecting the preformed base material to a gas plasma established in a vapor containing at least one amine compoung; (2) optionally treating the carbohydrate with a reagent which modifies said carbohydrate such that said carbohydrate is capable of reacting with the amino groups; (3) reacting said amino groups on the at least one -6a-wettable surface with the carbohydrate to immobilize the carbohydrate onto the at least one wettable surface; and (4) treating the surface-immobilized carbohydrate with a reagent to stabilize the bond between the carbohydrate and the at least one wettable surface, if required to obtain said hydrolytically stable bond.
In yet a further aspect, the invention provides a process for the manufacture of a wettable composite material, especially a biomedical device, e.g. an ophthalmic device, said' process cot»prising the following steps:
1. exposing the non-composite biomedical device in its desired final foam to a low pressure plasma in a vapor of at least one organic andlor inorganic compound under 1 o conditions whereby a thin film containing reactive groups is deposited on the desired surfaces) of the base material, 2. optionally, reacting the said reactive groups with an activating group, and/or with an oligofunctional compound having one or more functional groups capable of chemically reacting with the said reactive gn~ups,.or with the activated reactive groups, and having at least one additsonal functional group capable of chemicaDy reacting with a carbohydrate to produce an activated surface, 3. optionally treating thc-carbohydrate with a reagent which modifies the sand carbohydrate so that it is capable of reacting with the surface reactive or functional groups, 4. reacting the reactive groups or the functional groups with the carbohydrate, 2 0 5. optionally, treating the surface-immobilized carbohydrate with a reagent to stabilizre the bond between the carbohydrate and the surface.
The resulting material is preferably washed and suitably packed ready for use.
In yet a funher aspect, the invention provides a process for the manufacture of a wettable composite material, especially a biomedical device, e.g. an ophthalmic device, having 2 5 reactive groups inherently (a priori) present in the bulk mtiterial, said process comprising the following step(s):
- optionally, reacting the reactive groups inherently present in the bulk material of the non-composite biomedical device in its desired final form with an activating group, and/or with an oligofunctional compound having one or more functional groups capable of 3 o chemically reacting with the said reactive groups, or with the activated reactive groups, and having at least one functional group capable of chemically reacting with a carbohydrate to produce an activated stuface, - optionally treating the carbohydrate with a reagent which modif-~es the said carbohydrate so that it is capable of reacting with the surface reactive or functional groups, _7_ reacting the reactive groups or the functional groups with the carbohydrate, - optionally, treating the surface-immobilized carbohydrate with a reagent to stabilize the bond between the carbohydrate and the surface.
The invention is therefore directed to a composite material, especially a biomedical device, e.g. an ophthalmic device, preferably a contact lens, with one or more wettable surfaces capable of holding a continuous layer of aqueous fluid thereon which composite material comprises a bulk material and a hydrophilic coating characterized in that the hydrophilic coating consists of a carbohydrate attached covalently to reactive groups at the surface of the bulls material, either directly or via functional groups of an oligofunctional compound, said oligofunctional compound in turn having functional groups being capable of reacting with said reactive groups at the surface of the bulk material and with the carbohydrate, wherein said reactive groups are either inherently (a priori) present in the bulk material or wherein said reactive groups have been attached to the surface of the bulls material by a plasma surface preparation, as hereinbefore defined, as well as to a process of manufacture of such a composite material.
The bulls material may be e.g. any material conventionally used for the manufacture of biomedical devices, e.g. contact lenses, which are not hydrophilic per se.
Such materials are known to the skilled artisan and may comprise for example polysiloxanes, fluorinated (meth)acrylates or equivalent fluorinated comonomers derived e.g. from other polymerizable carboxylic acids, alkyl (meth)acrylates or equivalent alkyl comonomers derived from other polymerizable carboxylic acids, or fluorinated polyolefines, such as fluorinated ethylene propylene, or tetrafluoroethylene, preferably in combination with specific dioxols, such as perfluoro-2,2-dimethyl-1,3-dioxol. Examples of suitable bulls materials are e.g. Neofocon, Pasifocon, Telefocon, Silafocon, Fluorsilfocon, Paflufocon, TM iM -Silafocon, Elastofilcon, Fluorofocon or Teflon AF materials, such as Teflon ~1F 1600 or TM
Teflon AF 2400 which are copolymers of about 63 to 73 mol % of perfluoro-2,2-dimethyl-1,3-dioxol and about 37 to 27 mol % of tetrafluoroethylene, or of about 80 to 90 mol % of perfluoro-2,2-dimethyl-1,3-dioxol and about 20 to 10 mol % of tetrafluoroethylene.
The bulls material may also be e.g. any material conventionally used for the manufacture of biomedical devices, e.g. contact lenses, which are hydrophilic per se, since reactive groups, e.g. amine or hydroxy groups are inherently present in the bulk material and therefore also at the surface of a biomedical device manufactured therefrom.
Such WO 94/06485 ~ PCT/PP93/02420 _ materials are known to the skilled artisan. Typical examples comprise e.g.
Polymacon, Tefilcon, ll~tethafilcon, Deltafxlcon, Bu~lcon, Phemfilcon, Ocufilcon, Focofilcon, Etafilcon, ~Iefilcon, Yifilcon, Tetrafileon, PerF~lcon, Droxifilcon, Dimefilcor, Isofilcon, Mafilcon or Atlafilcon. Most of these materials are I~EMA based, but suitable materials may also be based on other underlying monomers or polymers having z~active groups, e.g.
hydroxy groups or amino groups, such as e.g. polyvinyl alcohol.
The bulls material may be any blood-contacting material conventionally used far the manufacture of renal dialysis membranes, blood storage bags, pacemaker leads or vascular grafts. For example, the bulk material may be a polyurethane, polydirnethylsiloxane, polytetrafluoroethylene, polyvinylchloride or DacronTM.
a Moreover, the bulk material may also be an inorganic or metallic base material with or without suitable reactive groups, e.g. ceramic, quartz, or metals, such as geld, or other polymeric or non-polymeric substrates. E.g. for implantable biomedical applications, ceramics, preferably coated with a polysaccharide, are very useful. In addition, e.g. for biosensor purposes, dextran coated base materials are expected to reduce nonspecific binding effects if the structure of the coating is well controlled. Biosensors may require polysaccharides on gold; quartz, or other non-polymeric substrates.
7Che reactive groups, inherently (a priori) present at the surface of the bulk material or having been introduced or attached. to the surface of the bulk material by a plasma surface preparation; as hereia~before defined, may be selected from a wide variety of groups~well known tc~ the skilled artisan. Typical'examples are e:g: hydroxy groups, amine groups, carboxy groups, carbonyl groups, aldehyde groups; sulfonic acid groups, sulfonyl chloride groups, groups being replaceable by amin~ or hydroxy groups, such as halo groups, or mixtures thereof Amino groups and hydroxy groups are preferred.
Suitable organic or inorganic compounds far the plasma surface preparation step are e.g.
ar~imonia, water vapor, carbon dioxide, carbon monoxide, noble gases, e.g.
argon, oxygen, ozone or air, alcohals, amines'or alkanones; preferably lower alkanols having up to eight carbon atoms; lower allcyl amines having up to eight carbon atoms, or lower alkanones having up to eight carbon atoms, e.g. methanol, ethanol, ammonia, methylamine, ethylamine, heptylamine, or acetone; ox many other compounds known to those skilled in the art of plasma surface preparation. It is also within the scope of this invention to use mixtures of the compounds mentioned hereinbefore.
The first step of deposition of plasma polymer thin film coatings containing on their surfaces reactive ~rou~s such as amine and hydroxyl groups is fully described in WO 89/11500 (Griesser et al.) and in Griesser H.J. and Chatelier It.C. Journal of Applied Polymer Science: Applied Polymer Symposium 46, 361-384 (1990);
Suitable activating compounds for the optional step 2 are e.g. anhydrides or activated esters, such as 2,2,2-trifluoroethanesulphonyl chloride, p-toluenesulphonyl chloride, cyanogen bromide or p-nitrophenylesters.
Suitable oligofunctional compounds for the optional step 2 have preferably up to four functional groups and are, more preferred, bifunctional. Preferred bifunctional compounds for step 2 are preferably epihalohydrins, bis-oxiranes or diisocyanates.
Typical examples are e.g. the diglycidyl ether of bisphenol A, 1,3-butadiene diepoxide or the diglycidyl ether of 1,4-butanediol. These bifunctional compounds yield an activated surface with pendant epoxy groups, halogen groups or isocyanato groups. However, the present invention is not limited to the use of epoxy, halogen or isocyanato groups as functional groups. Many other oligo- or bifunctional reactive compounds can effect the desired covalent crosslinking between a reactive group rich coating, e.g. a hydroxyl or amine rich coating; and a carbohydrate. For example, other suitable bifunctional compounds are diacid chlorides, ditosylates, dihydrazides and any compound which contains more than one functional group which can react with the reactive groups as hereinbefore defined. A
preferred embodiment of the invention is the use of epihalohydrins, bis-oxiranes (diglycidyl ethers) or diisocyanates as oligofunctional compounds. It is further preferred that said oligofunctional compounds, or in the preferred case the bifunctional compounds, have different reactivity with respect to their functional groups, or to their two functional groups, respectively.
Suitable epihalohydrins are e.g. epichlorohydrine or methylepichlorohydrin.
One class of bis-oxirane compounds comprises diglycidyl compounds of formula I
\o/ (I) - to -wherein D is an organic divalent radical and wherein each of the glycidyloyxy groups are covalently bonded to a carbon atom of D. Preferably the compounds of formula I
are polyglycidyl ethers or carboxylate esters.
The organic radical D may be aliphatic, heterocyclic, aromatic, or araliphatic which is bound to the glycidyl oxygen directly or through a carbonyl group.
In one preferred embodiment D is aliphatic. Especially suitable radicals include alkylene of up to 25 carbon atoms, or said alkylene interrupted by one or more hetero atoms, such as oxygen, or cyclohexylene.' More preferably, D is alkylene of 2 to 6 carbon atoms, or _CZ:.C4_~y~ene(Q-C2-C4-alkylene)p where p is 1 to 8. Also especially suitable are the aforementioned aliphatic radicals terminating in carbonyl groups to form the corresponding diglycidyl carboxylate ester.
In anothLrpreferred embodiment D is aromatic. Especially suitable aromatic radicals itnclude phenyl, biphenyl; phenyl-lower allcylene-phenyl, phenyloxyphenyl, or phenylsulfonylphenyl, which are further unsubstituted or are substituted by lower alkyl, lower allcoxy; or halo:
The term "lower", whenever used in the context of this invention and if not defined otherwise, defines groups having up to seven carbon atoms; preferably groups having up to four carbon atoms: Thus; for the reason of illustration; e.g. lower alkyl is alkyl having up'to 7 carbon atom, such'as methyl, ethyl; propyl; butyl; or hexyl, and lower alkoxy is allcoxy having up to 7 carbon atcims, such as methoxy, ethaxy, butoxy, or heptyloxy.
Another class of bis-oxirane compounds comprises polyglycidyl compounds of the formula ~
~o~ ~I>
wherein E is an organic divalent radical and wherein each of the glycidyl radicals aa~e covalently bonded to a nitrogen er carbon atom of E. Preferably E is aliphatic, aromatic, heterocyclic or araliphatic, as hereinbefore defined for radical D.
v~~ 9~ios4ss ~criE~~ioa~zo ~ -~ ~ :a J ..3. (J id - -In a preferred subembodiment E is a bivalent hydantoin radical which is bound to the glycidyl groups through the respective nuclear nitrogen atoms, and said hydantoin is otherwise unsubstituted or substituted by lower alkyl.
In an alternate preferred subembodiment E is alkylene of up to 6 carbon atoms.
A third class of bis-oxirane compounds are those of the formula III
C\ / "~R2 ~ ~"-c"2 ( ) ~ ~ f ~1 wherein m is 0, 1 or 2 and each R independently represents hydrogen or lower alkyl.
Also mixtures of the above bis-oxiranes of formulae I, II and III may be employed.
Suitable bis-oxiranes, most of which are readily available and all of which are known, and which can be used according to this invention; have been disclosed e.g. in US
patent 4,59$,122.
Suitable bis-oxiranes are e.g. the diglycidyl ether of bisphenol A, 1,3-butadiene diepoxide or the diglycidyl ether of 14-butanediol, divinylbenzene dnoxide, diglycidyl ether, limonene dioxide, vinylcyclohexene dioxide, the diglycidyl ether of bisphenol F, 3;4-epoxycyclohexylmethyl 3,4~epoxy-cyclohexane carbo~cylate, phthalic acid digl~cidyl ester, diglycidyl atniline, or oligoethyleneoxide diclycidylethers; such as di(ethyleneglycol) diglydicyl ether, tetra(ethyleneglycol) diglycidyl ether, or octa(ethyleneglycol) diglycidyl ether.
Suitable diisocyanates are generally aromatic; aliphatic or cycloaliphatic diisocyanates, or mixtures thereof. The aromatic moiety thereof is preferably phenyl, naphthyl or anthryl, which are unsubstituted or substituted by alkyl having up,to four carbon atoms, by alkoxy having up to four carbon atoms or by halo; preferably chloro, wherein twa aromatic anoieties may be connected by an ether bond or by an allcenylene group of up to four carbon atoms; the aliphatic moiety thereof is preferably alkyl having up to 10 carbon atoms; the cycloaliphatic gnoiety thereof is preferably cycloalkyl or bicycloalkyl having up to 6 carbon atoms in each cyclc~alkyl ring.
,, . ~ r:., .t.,.::
.S!.::~.'.~~. .. :~. ,~.~.... . . ~ '.. .~:.',;. .. 'i. :.~.: . .,.,. ~ -~,..
:.:..,~.. ,..:~...~. ., ~ .'.. , . .:'.. ,.;...." ".~.; ::.:
v n.... ~ ..............,,"".. .. .............,s..... . . , . .... . . ' ' . -...., . , , W~ 94/06485 PCT/EP93/02420 2~~~~~~
Examples of such diisocyanates are toluene-2,4-diisocyanate, toluene-2,6-diisocyanate, isophorone diisocyanate, ethylene diisacyanate, ethylidene diisocyanate, propylene-1,2-di-isocyanate, cyclohexylene-I,2-diisocyanate, cyclohexylene-1,4-diisocyanate, m-phenyle-ne-1,2-diisocyanate, 3,3'-diphenyl-4,4'-biphenylene diisocyanate, 4,4'-biphenylene diiso-cyanate, 4,4'-diphenylmethane diisocyanate, 3,3'-dichloro-4,4'-biphenylene diisocyanate, 4,4'-diphenyl diisocyanate, I,6-hexamethylene diisocyanate, 2,2,4-trimethyl-hexamethyle-ne diisocyanate, 1,4-tetramethylene diisocyanate, 1,10-decamethylene diisocyanate, cume-ne-2,4-diisocyanate, 1,5-naphthalene diisocyanate, methylene dicyclohexyl diisocyanate, 1,4-cyclohexylene diisocyanate, p-tetramethyl xylylene diisocyanate, p-phenylene-1,4-di-isocyanate, 4-methoxy-1,3~phenylene diisacyanate, 4-chloro-1,3-phenylene diisocyanate, 4-bromo-l,3-phenylene diisocyanate, 4-ethoxy-1,3-phenylene diisocyanate, 2,4-dimethyl-1,3-phenylene diisocyanate, 5,6-dimethyl-1,3-phenylene diisacyanate, 2,4-diisacyanatodi-phenylether, 4,4'-diisocyanatodiphenylether, benzidine diisocyanate, 4,6-dimethyl-1,3-phenylene dii5ocyanate, 9,10-anthracene diisocyanate, 4,4'-diisocyanatadibenzyl, 3,3'-di-methyl-4,4'-diisocyanatodiphenylmethane, 2,6-dimethyl-4,4'-diisocyanatodiphenyl, 2,4-di-isocyanatostilbene, 3,3'-dimethoxy~-4.,4'-diisocyanatodiphenyl, I,4-anthracene diiso-cyanate, 1;8-naphthalene diisocyanate, 1,3-bis-isocyanatomethyl-cyclohexane, or 4,4'-(dicyclohexyl)methane dvsocyanate.
Preferred are diisocyanates having different reactivity with respect to their two NCO
groups, such as isophorone diisocyanate; 2;4-toluene diisocyanate, or 2;2,4-trimethylhexamethylene diisocyanate.
Suitable carbohydrates according to this invention comprise natural products, modified carbohydrates and syntJhetic earbohydrates:'Examples far these groups of carbohydrates are sugars; such as monosaccharides; di- and oligosaccharides, cyclic oligosaccharides, linear polysaccharides, whether homopolysaccharides or heteropolysaccharides, branched polysaccharides, segment~,,d polysaccharides, lipopolysaccharides, glycoproteins and proteoglycans. The modified products or synthetic products may be modified e.g. by oxidation, ether~cation or esterification, they may further comprise functional groups such as aldehyde groups, acetal groups, ketal groups, acylamino groups, preferably acetylarryino groups, anhydro groups or lactone groups. They may fuzther have groups which niay be charged, sa~ch as -NH2, -COOH, -OS03H, or -OP(O)(OH)2.
Examples of suitable carbohydrates are known to the skilled artisan and can be found in W~ 94/Ob4~5 PCT/EP93/02420 conventional textbooks, or monographs. The following listing is exemplary only and not meant to restrict the invention:
Suitable sugars are e.g. glucosamin; galaktasamin, neuraminic acid, muraminic acid, sialinic acid, L-fucose, arabinose, xylose, glucuronic acid, gluconic acid or levoglucosan.
Suitable oligosaccarides are e:g: lactose, maltose, cellobiose, chitohexanose, trehalose, isomaltulose, leucrose.
Suitable polysacch~rrides and derivatives are e.g, hyaluronic acid, deacylated hyaluronic acid, chitosan, chitin 5Q, fucoidan, carrageenans, dextran, bhze dextran, aminated dextran, galaktomannian, glueomannan, pullulan, glycosaminoglycan, heparin, agarose, curdlan, pectin, pectic acid, xanthan, hydroxypropyl cellulose or chitosan, carboxymethyl cellulose or chitosan, emulsan, laminaran, inulin, pustulan, scleroglucan, schi2ophyllan, or mucopolysaccharides.
Further examples of suitable carbohydrates are D-ribose, L-arabinose, D-xylose, L-fucose, D-mannose, D-galactose; I?-glucosamine; muramic acid, D-galactosamine; D-gluocoronic acid, D-mannuronic acid, D-galacturonic acid,' L-glycero-D-manno-heptose, neuraminic acid. Further examples o~ polysaccharides are agarose, alginates, carea.geenan, cellulosics, such as acetate; carboxymethyl,'ethyl; hydroxyethyl, hydr~xypropyl, hydi-oxypropylmethyl, methyl cellulose, chitin / chitosan, dextran, furcellaran, gellan gum, guar gum; guts arabic, heparin, hyaluronic acid, hydroxypropyl guar, karaya gum, laminaran, locust bean gum; pectin (low or high methoxyi), rhamsan gum, starches, iragacant guru; welan gum; xanthan gum.
Examples of especially suitable xnonosaccharides include glycerol, threose, glucose, galactose and fructose. Examples of especially suitable ~ligosaecharides include sucrose, maltose, lactose arid cellobiose. Examples of especially suitable polysaccharides include dextrans; starches, dextrins; glycogens; inulin; glycosaminoglycans and mucopolysaccharides; further preferred are dextran, chitosan, hyaluronic acid, mucin, fucoidan; and gl~acosamin.
naturally occurring carbohydrates nnay be modified in order to enhance their reactivity with acravated surfaces. For example, oxidation of dextran with periodate yields aldehydes which can react with amines on the surface of the material; treatment of dextran with 2122~~
bromoacetic acid in alkaline solution places pendant carboxymethyl groups on the polysaccharide backbone which, in turn, can form ester or amide links with surface hydroxyls or amines, respectively; treatment of dextran with choroethylamine in alkaline solution places pendant aminomethyl groups on the polysaccharide backbone which, in turn, can react with surface 'epoxy, acid chloride or tosylate groups.
Step two may be performed by immersing the plasma treated material in a solution or vapour of oligo- or bifunctional compound. For example, the surface may be immersed in a solution of 0:1-5.0 ml epichlorohydrin (preferably 0.2-2.0 ml), and 10-100 ml of 0.4 ml of 0.4 M sodium hydroxide (preferably 20-30 ml} in 10-100 ml of diethyIene glycol dimethyl ether (preferably 20-30 m1) for 1-6 hours (preferably 4-6 hours) at 10-60°C
(preferably 20-30°C). Alternatively, the surface may be immersed in a solution containing 20 ml water, 0.4 ml 1,4-butanediol diglycidylether; and 1 ml benzyltrimethylammonium hydroxide at f0°C for 5 hours. The sample is then rinsed with water at room temperature.
The reaction between the carbohydrate and the reactive groups of the surface is performed in such a way that a highly water retaining carbohydrate layer is provided on the outermost surface of the novel composite material. Preferably the material with an activated surface is placed in a solution of carbohydrate for an appropriate time. For example the method described by S: Lofas and B. Johnsson in J. Chem. Soc.:
Chem.
Commun. 1526 (1990) may be used. Thus the surface can be reacted with 0.1-I5.0 g (preferably 2.0-5.0 g) of dextran (molecular weight 1,000-S,OOO;OOO Da;
preferably 500;000-2;000,000 Da) ins 1.0-50 ml (preferably 20-30 ml} of 0:01-5.0 M
(preferably 0.1-2.0 M) sodium hydroxide for 0.1-48 hours (preferably 20-25 hours) at IO-60°C
(preferably 20-30°C)~ Excess dextran is washed off by rinsing the sample in distilled water. Alternatively, the material may be immersed in a solution containing 20 ml water, 0.2 g dextran (molecular weight 1;000 to 40;000,000 Da (preferably 500,000 to 40,000,000 Da} and l ml benzyltrimethylamrnonium hydroxide at 60°C far 18 hours.
Again, excess dextran is washed off by rinsing the sample in distilled water.
The invention encompasses all such methods and the biomedical devices, e.g.
ophthalmic devices so obtained.
The biomedical: devices of the inventions are e:g. implantable biomedical devices, such as prostheses; vascular grafts, catheters, pacemakers or shunts, or ophthalmic devices. The ophthalmic device of the invention is e:g. a contact lens, an eye bandage or an intraocular . f .~~.~ ... ~': .'. .f., .
.7 . , J .
'. ( .
h ,..:
~~ S~
' t /'.t.~'y a. .
1a m ., .... . , . u. ;'.'.k _, ...m. . . _, . '.A"w.,.
.,.,n. .,.1;', v.... , ..1...... . ,.... I ..a . . .;.fir..,, i'fO 94106355 PCf/EP93/02420 2~.2~v~~
Lens, and preferably it is a contact lens.
In its broadest aspects the invention is directed to a composite material, especially a biomeclical device, e.g. an ophthalmic device, preferably a contact lens, with one or more, preferably one or two, wettable surfaces capable of holding a continous Iayer of aqueous fluid thereon which composite material comprises a bulk material and a hydrophilic coating characterized in that the hydrophilic coating consists of a carbohydrate, including a modified carbohydrate, attached covalently to reactive groups at the surface of the bulk material, either directly or via functional groups of an oligofunctional compound, said oligofunctional compound in turn having functional groups being capable of reacting with said reactive groups at the surface of the bulk material and with the carbohydrate, wherein said reactive groups are either inherently (a priori) present in the bulk material or wherein said reactive groups have been attached to the surface of the bulk material by a plasma surface preparation.
A, preferred subembodiment of the invention is a biomedical device, e.g. an ophthalmic device wherein reactive groups are inherently present in the bulk material and wherein the oligofunctional compound is a bis-oxirane or an epihalohydrin; preferably a bis-oxirane.
A further:preferred subembodiment of the invention is a biomedical device, e.g. an ophthalmic device wherein reactive groups are inherently present in the bulk material, wherein the oligofunctional compound is a bis-oxirane and the carbohydrate is a polysaccharide: Said carbohydrate is preferably selected from dextran, chitosan, hyaluronic acid, mucin; fucoidan; and ghcosamin.
A f~er preferred subembodiment of the invention is a biomedical device, e.g.
an ophthalmic device wherein reactive groups are inherently present in the bulk material, wherein he c~Iigofur~ctional compound is a diisocyanate and the carbohydrate is a non-polysaccharide carbohydrate.
A further preferred subembodiment of the izwention is a biomedical device, e.g: an ophthalmic device wherein reactive groups are inherently present in the bulk material, wherein the oligofunetional compound is a diisoeyanate and the carbohydrate is dextran.
An additionally preferred subembodiment of the invention is a biomedical device, e.g. an ophthalmic device wherein reactive groups are inherently present in the bulk material, and 2~.~~3~~
wherein the oligofunctional compound has different reactivity with respect to its functional groups. Such ~n oligofunctional compound may be e.g. a bis-oxirane.having different reactivity with respect to its two functional groups, such as for example limonene dioxide, vinylcyclohexene dioxide; 3,4-epoxycyclohexylmethyl 3,4-epoxy-cyclohexane carboxylate, or it maybe e.g. a diisocyanate having different reactivity with respect to its two functional groups, such as for example isophorone diisocyanate, 2,4-toluene diisocyanate, or 2,2,4-trimethylhexamethylene diisocyanate.
Another preferred embodiment of the invention is a biomedical device, e.g. an ophthalmic device wherein said reactive groups have been attached to said surface by a plasma surface preparation and wherein the oligofuncdonal compound is selected from an epihalohydrin, bis-oxirane; diisocyanate, diacid chloride, and ditosylate.
Within this embodiment it is preferred that the oligofunctional compound is a bis-oxirane.
It is further preferred that the oligofunctional compound is a bis-oxirane having different reactivity with respect to its two: functional groups:
Another preferred embodiment of the invention is a biomedical device, e.g. an ophthalmic device wherein said reactive groups have been attached to said surface by a plasma s~a~ preparation and wherein the oligofunctional compound is a bis-oxirane and the carbohydrate is a polysaccharide; which is preferably selected from dextran;
chitosan, hyaluronic acid, mucin, fucoidan, and glucosamin:
Another preferred embodiment of the invention is a biomedical device, e.g. an ophthalmic device wherein said reaotive groups have been attached to said surface by a plasma surface preparation and wherein the oligofunctional compound is a diisocyanate. It is further preferred that the oligofunctional compound is a diisocyanate having different reactivity with respect to its two functional groups.
Another preferred embodiment of the invention is a biomedical device, e.g. an ophthalmic device wherein said reactive groups have 'peen attached to said surface by a plasma surface preparation and wherein the oligofunctional compound is a diisocyanate and the carbohydrate is a polysaccharide; which is preferably selected from dextran, chitosan, hyaluronic acid; mucin, fucoidan; and glucosamin.
A further-preferred subembodiment of the invention is a biomedical device, e.g. an ophthalmic device wherein reactive groups are inherently present in the bulk material, wherein the carbohydrate is a polysaccharide which is directly bonded to the reactive groups. Said carbohydrate is preferably selected from dextran, chitosan, hyaluronic acid, mucin, fucoidan, and glucosamin.
A further preferred subembodiment of the invention is a biomedical device, e.g. an ophthalmic device wherein reactive groups are inherently present in the bulls material, wherein the carbohydrate is a non-polysaccharide carbohydrate which is directly bonded to the reactive groups.
A further preferred subembodinnentof the invention is a biomedical device, e.g. an ophthalmic device wherein'reactive groups are inherently present in the bulk material, wherein the carbohydrate is dextran which is directly bonded to the reactive groups.
Another preferred embodiment of the invention is a biomedicai device, e.g. an.
ophthalmic device wherein said reactive groups have been attached to said surface by a plasma surface preparation and wherein the carbohydrate is a polysaccharide, which is dixecdy bonded o the reactive groups. Said carbohydrate is preferably selected from dextran, I
chitosan, hyaluronic acid, mucin; fucoidan, and glucosamin.
Another preferred embodiment of the invention is a biomedical device, e.g. an ophthalmic device wherein said reactive groups which have been attached to said surface by a plasma surface preparation are hydroxy or amino groups and wherein the carbohydrate which is directly bonded to the reactive groups is preferably selected from dextran, ehitosan, hyaluronic acid, mucin, fucoidanand glucosamin, and is most preferably dextran.
The biomedical devices, e:g. ophthalmic devices according to the present invention have a variety of unexpected advances over those of the' prior art- which make those devices, especially contact lenses, according to the invention very suitable for practical purposes, e.gas contact lenses for extended wean For example, they do have a high surface wettability which can be demonstrated by their contact angles, their water retention and their water-film break up time or tear film break up time. The water retention time is closely related to the water-film break up time ("gUT°') and the tear film break up time, in that a high water retention time results in a high water-film break up time or tear film break up time.
WO 94!06485 ~ PCT/EP93I02420 ~"w"~a:
212~3~~
_ Ig _ In addition the biomedical devices; e.g. ophthalmic devices, such as contact lenses according to this invention have a very pronounced biocompatibility combined with good mechanical properties. For example, there are generally no adverse eye effects observed, while the adsorption of proteins or lipids is low, also salt deposit formation is lower than with conventional contact lenses. Generally one may state that there is low fouling, low microbial adhesion and low bioerosion while the good mechanical properties can be for example found in a low friction coefficient and low abrasion properties.
In summary the ophthalmic devices according to this invention, such as contact lenses, provide a combination of low spoilation with respect to cell debris, cosmetics, dust or dirt, solvent vapors or chemicals, with a high comfort for the patient wearing such contact lenses in view of the soft hydrogel surface which for example provides a very good on-eye movement of the contact lenses:
t :."
: ".~, : ~:s. ~.'.
.:, ;fi . r ....:J~.., .?...r A
1 5:
.. l .... '~o,pp.
.1~.'.. .. ) .G. a k..
., it. .
..r. . r.. .Y.,...r ...
a... t......r . .1:.:~.~.~, .. .. .. .. .n....tv: . , . . . ...n..v. ,.. .. .
.. .. «~:~'!. .. .. , .. , ....
'1~V~ 94/0645 P~'/EI'~3/02420 (CI-)-NH..--CH~.CH-CH2 --O ' , ~ ~ O--CHZ-CH-CH2 CH3 or H
Scheme II
;, (CL) - OH + C~~--CH.-CH2.~._CI --s' (CL) - O--CH2-C~. ~ H2 O O
wherein (CL) denotes the surface of a contact lens, (CL)-NH2 denotes an exemplary amino group present at the surface of said contact lens and (CL}-OH denotes an exemplary hydroxy group present at the surface of Said Contact Iens.
A further reaction scheme shows the covalent attachment of a carbohydrate onto epoxy groups bonded to a biomedical device, e:g. a contact lens:
Scheme IZI
R ~ ~O- CH2 H ~ 0 H
(CL) - O-.-GH2.---CH-CHI + pF~i H -_-~~ Hp~ p-R2 'fH'''' OH °
R~-O- CHz H H O H
(~~) _ O.--CH2-CH-CH2---O ~H H ~_R2 ~' H ()H
OH
vyherein (CL} denotes the surface of a contact lens, and F~.~ and R2 have the meaning of a conventional residue extending the chain of a carbohydrate.
Where the carbohyd~~ate contains a traps vicinal diol the carbohydrate, such as e.g.
dextran, may be oxidized in part with an appropriate oxidizing agent, e.g.
with sodium periadate, in order to obtain ring cleavage and formation of aldehyde functions. Said WO 94/(Dfi48S PCT/EP93/02420 -2a-aldehyde functions may be reacted with amino groups, present as reactive groups or as functional groups at the surface of the biomedical device, to form an -N=CI3-group. Said groups may be reduced with a suitable reducing agent to a hydrolytically stable -I'~H-CH2-group linking the carbohydrate molecule to the device surface.
Without limiting the invention, further combinations of chemical groups which may be reacted with each other in order to obtain composite materials according to this invention are e.g. as follows: A carbonyl reactive group at the surface of the device is reacted with a hydrazide functional group of a dihydrazade while the other hydrazide functional group thereof is reacted with an aldehyde group of a carbohydrate. An aldehyde reactive group at the surface of the device is reacted with an amino group of a carbohydrate, and reduced if desired. An amino reactive group or a hydroxy reactive group at the surface of the device is reacted with an epoxide functional group of a diepoxide while the other epoxide functional group thereof is reacted with an amino or hydroxy group of a carbohydrate. An amino reactive group or a hydroxy reactive group at the surface of the device is reacted with one functional end group of an epichlorohydrin while the other functional end group thereof is reacted with an amino or hydroxy group of a carbohydrate. An amino reactive group or a hydroxy reactive group at the surface of the device is reacted with an isocyanato functional group of a diisocyanate while the other isocyanato functional group thereof is reacted with an amino or hydroxy group~of a carbohydrate. A carboxy group at the surface of the device is reacted with an amino group of a carbohydrate. A
reactive gr~up at he surface of the device which is replaceable by an amino yr hydroxy group is replaced by an amino or hydroxy group of a carbohydrate. s In the examples, if not otherwise indicated; temperatures are given in degrees Celsius, and contact angles are given in degrees.
Example 1 (Comparative): Commercially available fluoropolymer (Fluorofocon ATM) contact lenses are'rerr~oved from storage in saline solution, rinsed with distilled water and inserted for in vivo testing (with unpreserved, buffered saline Solution).
Each lens is fitted tb a subject who is unadapted to contact lens wear. Subjects are chosen to whom the lenses could be adequately fitted The measured variables are: (1) overall wettability, (2) front surface break up time (FS BU'T); (3)' speed of surface drying, (4) surface coverage. The variables are assessed immediately after insertion and again ten minutes after insertion.
Example 2 (Comparative): C~mmercially available silicone elastomer (Elastofilcon ~~ ~~J~~J
ATM) contact lenses are removed from storage in saline solution, rinsed with distilled water and then allowed to dry in air prior to measurement of air/water contact angles.
Contact angles are measu~ned using a modified Kernco-G2 contact angle goniometer. By placing the sample on a flat stage and placing a drop of distilled water on the apex of the anterior lens surface usin ~ micrometer driven s 'n e, and then ali 'n rotatable cross g Yn g ~ g hairs in the eyepiece at a tangent to the cazrvature of the lens and the drop at the water/air/lens interface, the sessile contact angle (SCA) can be measured. The micrometer driven syringe is then used tea gradually increase the volume of the drop by injecting more water into it, just until the drop begins to advance across the surface, at which point the advancing contact angle (ACA) is measured using the rotatable crosshairs. The micrometer driven syringe is then used to gradually decrease the volume of the drop by withdrawing water from it, until the drop begins to recede across the surface, at which point the receding contact angle (RCA) is measured.
Exam 1e 3: Commercial) avaiiable'RGP fluoro of er luorofocon ATM
P Y P Ym ~ ) contact lenses are coated with a thin polymer film produced by plasma polymerization of methanol vapour at a pressure of 0.7 torn, ihput power of 10 watts, signal frequency of 300 kHz and treatment time of l minute:
The plasma modified contact lenses are reacted with 0.235 ml of epichlorohydrin in a mixture of 25 mI 'of 0.4 M Na~H and 25 ml of diethylene glycol dimethyl ether at 20°C
for 4 hours. The lenses are then washed 3 times in distillecl water, twice with ethanol and again 3 times in distilled water.
Dexaan is attached to the ~pichlorhydrin treated lens surfaces by soaking in a solution of 3:0 g Dextran dissolved in 25 ml of 0:1 M NaOH for 20 hours. The lenses are then washed times in distilled water and allowed to dry in air before measuring contact angles. The treated lenses are then stored in saline solution before testing under identical conditions as example 1 The in vitro data in Table 1 reveal a decrease in sessile, advancing and receding air/water contact angles of the contact lenses when the surfaces are treated according to this invention.
The in vivo data in Table 2-reveal an increase in wettability by tear film when the surfaces ~:~ ~ Y '. S n ,.r . A .- , ."... .; , ~a: . . ~ : : ~~ i~. ;',~ .,', ,,.;',. ~ ..~~ ... ~,..:. . n...
...: ~ r. ;~.: . , ~. ~ .; -...' , -.,~:, ,. .'~. . "o :~.. ~ ~.'. ,.
,.......-,. ... .. ._...:,, ..,.,;~:v'..y, .;...,.,.. .'.'1'; ~....._..,, ..~:.;:,~,., ',~....':' . : .".':.-. ~ .'..::,.;.,,. .,. :°,'. .~...:.y ,.,,...:: , ;.....,.:_..., VV~ 94/06485 PCT/EP93/0?~t20 ~~~~J~~ sin";
are treated according to this invention.
Example 4: Example 4 is identical to Example 3, except that the contact lenses are commercially available silicone elastomer (Elastofilcon ATM) contact lenses, and measurements of air/water contact angles are made after rinsing with distilled water and allowed to dry in air. The results in ''fable 1 reveal a decrease in sessile, advancing and receding air/water contact angles of the contact lenses when the surfaces are treated aGCOrdlng t0 thlS inYentlOn.
Brief description of Tables 1 and 2 Table 1 shows the change in air/water contact angles consetluent on attachment of polysaccharide onto the surface of RGP fluoropolymer (Fluorofocon ATM) and silicone elastomer (Elastofilcon ATM) contact lenses.
Tabls 2 shows the effect of grafted polysaccharide on the time taken for the contact lens to dry; for RGP fluoropolymer (Fluorofocon ATM) contact lenses.
Table 1 Contact L.~ns~ SCA* ~,CA*RCA*
Fluorofocon ATM lenses:
Untreated lenses 111 119 47 Lenses with lDextran MW = 500;000 90 95 9 Lenses with Dextran M'~ = 2'000 80 85 4 Elastoftlcon ATM lenses:
iUntreated lenses x 107 61 tenses with Dextrin (M'W .= 500,000)99 104 45 Lenses with Dextran (MW - 2'000,000)93 99 17 * SCA;
ACA and RCA are the sessile, advancing and receding air/water contact azagles respectively.
WO 94/064$5 PGT/EP93/02420 ?1?~'a~~
Table 2 Variable ~ti~y After 10 minutes Example ComparativeExample Comparative exare~ple example Wettabilit 3.5 +/- 2:5 +/ 1:3 3.3 +/- 1.9 +/-* 0.9 0.6 0.7 FS BUT# (sees)10 +/: 7 +/ 4 9 +/ 2 S +/- 2 Speed of drying+1.4 +/- 2:1 +/ 0.7 1.3 +/- 2:9 +/-- 0.6 0:4 0.2 ~' Wenabitity 0 = surface completely non-wetting I -- very thin tear layer, fast break up time (BUT) 2 = moderately thin layer;
fast BUT
3 = tear layer slightly thin, BUT approximately equal to interblink interval 4 = tear Iayer thick and smooth, no dry patches, BUT greater than interblinlc interval #FSBUT
Front surface break up time' + Speed of drying 1='slow 2 = moderate 3 = fast Exatnpte.'S
(Comparison):
An important criterion for the usefulness of the present t.
a invention is the dme taken for water to recede from 50 % of the surface of a substrate;
such-as a contact lens:
This parameter is' abbreviated' "WRT"' and presented in secomds in this example and hereinafter, The bulls material used is fluorinated ethylene propylene.
This material, without modification of its surface has a WRT of < 1 second.
Example 6: A flat substrate of fluorinated ethylene propylene is subjected to a plasma treatment'in the presence of heptylamane.
I g of polysaccharide in 200 ml water is treated with 3 g NaI44 and, reacted with the plasma treated ubstrate having amino groups at its surface in the presence of NaCNBH3 at a pH
of 6 to 9. A substrate with a hydrophilic coating is obtained for which the following time taken for water to recede from SO
% of the urface (WRT) is'measured:
polysaccharide MW WRT
(kDa) (see) wo ~aeo6ass Pcre~~93eo2aao 2~.2~~~~
a) ~ dextran 9.3 180 b) dextran 74.2 180 c) dextran 515. 180 d) dextran 2000 180 e) blue dextrain 2000 180 f) pectic acid n.d. 180 g} polyquat JR30M n.d. 90 Example 7: A flat substrate of fluorinated ethylene propylene is subjected to a plasma treatment in the presence of methanol: 7:'he substrate having hydroxy groups at its surface is treated with 1,4-butanediol diglycidyl ether in the presence of benzyltrimettaylammo-nium hydroxide and with dextran. A substrate with a hydrophilic coating is obtained fox which the following tune taken foz~ water to recede from 50 % of the surface (WRT) is measured:
polysaccharide M~ WRT
(kDa) (sec) a} dextran - 515 75 b) dextranu 2000 90 dextran 2000 210 d) dextran ~-40000 >300 .
In the f~llowing examples 1,4-butanetiiol diglycidyl ether is replaced by di(ethyleneglycol)diglycidyl ethsr (example e), by tetra(ethyleneglycol)diglycidyl ether (example f) or by octa(ethylene~Iycol)diglycidyl ether (example g):
e) ' dextran 2000 150 dextran 20t~0 90 g} dextran 2000 13S
example 8; An Elastofilcon contact lens is subjected to a plasma treatment in the presence of heptylamine. Dextran with a molecular weight (MVi~ of 74.2 kDa is treated with NaIOq/NaChIBH3 and reacted with the plasma treated contact lens having amino groups at its surface. A contact lens with a hydrophilic coating is obtained for which a time taken for water to recede from 5'0 % of the surface (WRT) of 180 seconds is measured.
Example 9: A Tefilcon contact lens is subjected to a plasma treatment in the presence of heptylamine. Dextran with a molecular weight (MW) of 74.2 kDa is treated with NaI04/NaCNBH3 and reacted with the plasma treated contact lens having amino groups at its surface. A contact lens with a hydrophilic coating is obtained for which a time taken for water to recede from 50 % of the surface (WRT) of 90 seconds is measured.
By contrast, a Tefilcon contact lens, without modification of its surface, has a WRT of 10 seconds.
TM
Example 10: A flat substrate of a) polyurethane, b) glass and c) Al-Kapton is subjected to a plasma treatment in the presence of heptylamine. A polysaccharide is treated with NaI04/NaCNBH3 and reacted with the plasma treated substrate having amino groups at its surface. A substrate with a hydrophilic coating is obtained for which the following time taken for water to recede from 50 % of the surface (WRT) is measured:
polysaccharide MW WRT
(kDa) (sec) a) dextran 74.2 900 b) dextran 74.2 120 c) dextran 74.2 120 Example 11: A silicone film, made from IJV - cured silicone PS 2067 (Huls America Inc, Bristol, USA) by casting it on a Folanorm foil (Folex ~, Zurich, Switzerland) and irradiation, is placed in an RF-GDP system (radio frequency glow discharge plasma) and the system is evacuated to 0.1 mbar. The film is exposed at a pressure of 0.1 mbar to an oxygen plasma at a power of about 40 W, at an oxygen flow of 10 nanocubic centimeters for 30 seconds, thereafter to air with release of the vacuum.
Example 12: A polybutadiene film, made from a tetrahydrofuran solution of poly(1,2-syndiotactic butadiene) (Polysciences, Inc., cat # 16317) by casting said solution TM
on a Folanorm foil and evaporating the tetrahydrofuran under a nitrogen flow, is modified by the method described in example 11.
WO 94106485 PCf/EP93l02420 2~.2~3~3 -26=
Example 13~ The plasma treated silicone film of example I 1 is placed into a desiccator over about 5 ml of 2,4-tolylene diisocyanate (2,4-TDn. The desiccator is heated to 50°C
and evaCUated to 0.008 mbar: The reaction with 2,4-TDI vapors is carried out for 2.S
hours. After cooling to room temperature the film is taken off, washed vigorously with dry acetone and soaked in a DMSO solution (comprising S % LiCI) of chitosan for 8 hows.
The modified film is washed thereafter 24 hours with water, dried and analyzed.
Examples 14 to I6: The following films are treated according to the method of example 13 except where specified otherwise:
Example 14: The oxygen plasma treated polybutadiene film of example L2. Time of vapor reaction is 2~S hours.
Example 15: A poly(hydroxyethyL methaerylate) (p-HEMA) film made from a solution consisting of HEMA (92 °Jo), ethylene glycol dimethacrylate (5 %) and, as a photoinitiator, Irgacure 184 (3 %) by casting it on a Folanorm foil and UV - irradiation. Time of vapor reaction is 6 hours: Tirne of reaction with chitosan is only 30 minutes.
Example l6: A polyvinyl alcohol' film (PVA) made from a DMSO solution of PVA
(Fluky AG) (99 %) and isophorone diisocyanate (IPDn, (Aldrich) (1 %) by casting it on a Folanorm foil and heating to 70°C for 2 hours under reduced pressure.
Time of vapor reaction is 6 hours. Time of reaction with chitosan is only .~i0 minutes.
The-following table lists the contact angles ("CA"); measured with a system G
40 (Kriiss GmbH, Hamburg Germany), of the polymeric films before treatment and after treatment:
Example Material CA' before CA after treatment (°) treatment (°) 13 silicone 100.4 56.9 14 polybutadiene 79:5 52.5 15 p'-HEMA 78:4 67.5 I6 pVA 47:1 31.5 Examples l7 to 20: Examples 13 to lb' are repeated with the same 2,4-TDI vapor modified films; but using, itrstead of the step of soaking in a chitosan solution, the step of WO 94/06485 ~ PCT/EP93102420 2.~~ZJ~~
_27_ soaking in a 1 % solution of hyaluronic acid, comprising about 1 mg of catalyst (DBTDL), in DMSO. The hyaluronic acid is obtained from Czechoslovakia (Product ZD
Straznice, CSFR).
The following table lists the contact angles ("CA"), measured with a system G
40 (Kruss GmbH; Hamburg Germany), of the polymeric films before tmatment and after treatment:
Example Material CA before CA after ~a~ent (°) treatment (°) 17 silicone 100.4 57.0 I g polybutadiene 79.5 68.0 19 p-HEMA 77:8 58.3 20 PYA 47.1 42.1 Examples 21 to 24: Polymeric films as described in ex:unples 13 to I6 are soaked in a °!0 2,4-TDl solution in a solvent incapable to swell the polymer (for solvent information see table hereinafter): The reactions are carried out at room temperature, under nitrogen gas for 12 hours. Afmr reaction the films are washed in acetone and dried under reduced pressure. The films arse thereafter soaked in a 1 % DMSO solution (comprising 5 °lo LiCI) of chitosan for 24 hours. The modified films are washed thereafter .for 24 hours with distilled water, dried'and analyzed.
The following table lists the contact angles ("CA"), measured with a system G
40 (ICruss GmbH, Hamburg Germany), of the polymeric films before treatment and after treatment:
Example ' Material CA before CA after (Solvent) treatment (°) treatment (°) 2 i silicone I00~4 59.8 (DMSO) 22 polybutadiene 79:5 58.0 (D~sO>
23 p-HEMA ?78 54.0 (tetrahydrofurane and diethylether) wo ~4ro6ass Pcri~rP~3rozazo 24 PVA 47.1 3?.5 (acetonitril) Examples 2S to 27: Examples 22 to 24 are repeated with the same 2,4-TDI
solution modified films, but using, instead of the step of soaking in a chitosan solution, the step of soaking in a 1 % solution of hyaluionic acid, comprising about 1 mg of catalyst (DBTDL), in DMSC?.
The following table lists the contact angles ("CA"), measured with a system G
40 (Kriiss GmbH, Hamburg Germany); of the polymeric films before treatment and after treatment:
Example Material CA before CA after heatment (°) treatment (°) 25 polybutadiene 7~.5 59.1 26 g_HEMA ? 8.0 55.1 27 PVA 48.U 38.0 Example 28: Washed and lyophilized STD TM contact lenses (from CIBA Vision, Atlanta, Tefilcon), based on a crosslinked polymer of p-HEMA; are soaked in a mixture of ml of tetrahydrofurane, 5 ml of diethylether, 0.2 g of isophorone diisocyanate (IPDI) and mg of catalyst (DBTDL)The reaction proceeds at room temperature under nitrogen flow for 12 hours. Thereafter the lenses axe washed with ace,tone~ dried and soaked in a 0.5 % solution of a carbohydrate in DMSO (comprising 5 % LiCI) and (except for example 28 d) D~TDL as a'catatyst. After 1 to 2 hours the lenses are vigorously washed with water, dried and analyzed.
The following table lists the contact angles ("CA"), measured with a system G
40 (I~riiss ' GmbH, Hamburg Germany), of the contact lenses after treatment (for comparison: the contact angle of an untreated STD contact lens is 77 - 78 °):
Example carbohydrate CA after treatment (°) a) Mucin (Sigma) 53.4 b) Fucoidan 50.5 Dextrah . 26.8 VVV9 94/(16485 PG°flEP93/02420 ,~~.<d~~~
d) Glucosamine (Fluke) 38.9 Example 29: Washed and lyophilized EXCELENS Th'1 contact lenses (from CIBA
Vision, Atlanta, Attafilcon), based on a crosslinked polymer of PYA, are soaked in a t mixture of 5 ml of tetrahydrofurane, 5 ml of diethylether, 0.2 g of isophorone ciiisocyanate (IPDI) and 10 mg of catalyst (DBTDL). The reaction proceeds at room temperature under nitrogen for 12 hours. Thereafter the lenses are washed with acetone, dried and soaked in a 0.5 °lo solution of a carbohydrate in D1V1S0 (comprising 5 % LiCI) and (except for example 29 a) DBTDL as a catalyst. After 1 to 2 hours the lenses are vigorously washed with water, dried and analyzed.
The following table lists the contact angles ("CA"), measured with a system G
40 (Krizss GmbH, Hamburg Germany), of the contact lenses after treatment (for comparison:
the contact angle of an untreated EXCELENS contact lens is 69 - 70 °):
Example carbohydrate CA after treatment (°) a) Chitosan 63.1 b) Fucoidan (Sigana) 61.3 c) Dextran (Fluke) 44.9 Exempts 30: A flat substrate of fluorinated ethylene prop;/lene (FEP) or perfluorapolyether(FFPE) is subjected to a plasma treatment in the presence of a) ammonia, b) ~thylenrr diaxnine or c) heptylamine. Dextrari of '74.2 kDa molecular weight is treated with NaIO,q/NaCNBH3 and reacted with the plasma treated substrate having amino groups at its surface: A substrate with a hydrophilic coating is obtained for which the following time taken for water to recede from 50 °lo of the surface (WRT) is measured:
substrate plasma gas WIZT (sec) a) FEP ammonia 160 b) FEP ethylene 160 diamine c) PFPE heptylamine 110 Example 3I: Different contact lenses are subjected to a plasma treatment in the presence ~~.223~~
of ammonia or hept~lamine. Dextran of 74.2 kDa molecular weight is treated with NaIO4lNaCNBH~ and reacted with the plasma treated contact lenses having amino groups at their surface. Contact lenses with a hydrophilic coating are obtained for which the following time taken for water to recede from s0 °lo of the surface (WRT) is measured:
contact lens plasma gas WRT (sec) material
Claims (19)
1. A composite material having at least one wettable surface capable of holding a continuous layer of aqueous fluid therein, which material comprises:
(a) a bulk base material, and (b) a hydrophilic coating, wherein the hydrophilic coating consists of a carbohydrate directly and covalently attached by a hydrolytically stable bond to amino groups at the surface of the bulk base material, wherein said amino groups are either inherently present in the base material or have been attached to the surface of the bulk base material by plasma surface treatment.
(a) a bulk base material, and (b) a hydrophilic coating, wherein the hydrophilic coating consists of a carbohydrate directly and covalently attached by a hydrolytically stable bond to amino groups at the surface of the bulk base material, wherein said amino groups are either inherently present in the base material or have been attached to the surface of the bulk base material by plasma surface treatment.
2. A composite material according to claim 1 wherein the amino groups are inherently present in the base material.
3. A composite material according to claim 1 wherein said amino groups have been attached to said surface by plasma surface treatment.
4. A composite material according to any one of claims 1 to 3, wherein the carbohydrate is a polysaccharide.
5. A composite material according to any one of claims 1 to 3, wherein the carbohydrate is selected from dextran, chitosan, hyaluronic acid, mucin, and fucoidan.
6. A composite material according to claim 1 wherein amino groups are inherently present in the base material, wherein the carbohydrate is a non-polysaccharide carbohydrate.
7. A composite material according to claim 1 wherein amino groups are inherently present in the base material, and wherein the carbohydrate is dextran.
8. A composite material according to claim 1, wherein the amino groups are covalently attached to the surface of preformed base material by subjecting the preformed base material to a low pressure plasma in a vapor of an alkylamine having up to eight carbon atoms under conditions whereby amino groups are formed on the desired surface of the base material.
9. A composite material according to claim 8, wherein the alkyl amine is heptylamine.
10. A composite material according to claim 8, wherein the alkyl amine is ethylamine.
11. A composite material according to claim 8, wherein the alkyl amine is methylamine.
12. A composite material according to any one of claims 1 to 11 which is a biomedical device.
13. A composite material according to any one of claims 1 to 11 which is an ophthalmic device.
14. A composite material according to any one of claims 1 to 11 which is a contact lens.
15. A process for the manufacture of a wettable composite material with at least one wettable surface capable of holding a continuous layer of aqueous fluid thereon, wherein said composite material includes a bulk base material and a hydrophilic coating of a carbohydrate directly attached covalently by a hydrolytically stable bond to amino groups at the at least one wettable surface of the base material, said process comprising the steps of:
(1) covalently attaching amino groups onto the at least one wettable surface of a preformed base material by subjecting the preformed base material to a gas plasma established in a vapor containing at least one amine compound;
(2) optionally treating the carbohydrate with a reagent which modifies said carbohydrate such that said carbohydrate is capable of reacting with the amino groups;
(3) reacting said amino groups on the at least one wettable surface with the carbohydrate to immobilize the carbohydrate onto the at least one wettable surface; and (4) treating the surface-immobilized carbohydrate with a reagent to stabilize the bond between the carbohydrate and the at least one wettable surface, if required to obtain said hydrolytically stable bond.
(1) covalently attaching amino groups onto the at least one wettable surface of a preformed base material by subjecting the preformed base material to a gas plasma established in a vapor containing at least one amine compound;
(2) optionally treating the carbohydrate with a reagent which modifies said carbohydrate such that said carbohydrate is capable of reacting with the amino groups;
(3) reacting said amino groups on the at least one wettable surface with the carbohydrate to immobilize the carbohydrate onto the at least one wettable surface; and (4) treating the surface-immobilized carbohydrate with a reagent to stabilize the bond between the carbohydrate and the at least one wettable surface, if required to obtain said hydrolytically stable bond.
16. A process of claim 15, wherein the amine is an alkyl amine having up to eight carbon atoms.
17. A process of claim 16, wherein the alkyl amine is heptylamine.
18. A process of claim 16, wherein the alkyl amine is ethylamine.
19. A process of claim 16, wherein the alkyl amine is methylamine.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPL4710/92 | 1992-09-14 | ||
AUPL471092 | 1992-09-14 | ||
PCT/EP1993/002420 WO1994006485A1 (en) | 1992-09-14 | 1993-09-08 | Multilayer materials |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2122363A1 CA2122363A1 (en) | 1994-03-31 |
CA2122363C true CA2122363C (en) | 2005-08-16 |
Family
ID=3776417
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002122363A Expired - Fee Related CA2122363C (en) | 1992-09-14 | 1993-09-08 | Coated composite material with wettable surface |
Country Status (18)
Country | Link |
---|---|
US (2) | US6623747B1 (en) |
EP (2) | EP0613381B1 (en) |
JP (2) | JP3650394B2 (en) |
CN (1) | CN1052167C (en) |
AT (1) | ATE212864T1 (en) |
CA (1) | CA2122363C (en) |
CZ (1) | CZ146394A3 (en) |
DE (1) | DE69331539T2 (en) |
FI (1) | FI942204A (en) |
HU (1) | HU216746B (en) |
IL (1) | IL106922A (en) |
MX (1) | MX9305597A (en) |
NZ (1) | NZ255408A (en) |
PL (1) | PL177980B1 (en) |
SG (1) | SG49616A1 (en) |
TW (1) | TW311120B (en) |
WO (1) | WO1994006485A1 (en) |
ZA (1) | ZA936728B (en) |
Families Citing this family (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL106922A (en) | 1992-09-14 | 1998-08-16 | Novartis Ag | Composite materials with one or more wettable surfaces and process for their preparation |
PL182804B1 (en) * | 1995-02-07 | 2002-03-29 | Fidia Advanced Biopolymers | Method of coating objects with hialuronic acid, its derivatives and semi-synthetic polymers |
US6355255B1 (en) | 1998-12-07 | 2002-03-12 | Regents Of The University Of Minnesota | Streptococcal C5a peptidase vaccine |
AUPN960696A0 (en) | 1996-05-02 | 1996-05-23 | Commonwealth Scientific And Industrial Research Organisation | Surface modification of polymers |
AR009439A1 (en) * | 1996-12-23 | 2000-04-12 | Novartis Ag | AN ARTICLE THAT INCLUDES A SUBSTRATE WITH A PRIMARY POLYMERIC COATING THAT CARRIES REACTIVE GROUPS PREDOMINANTLY ON ITS SURFACE, A METHOD FOR PREPARING SUCH AN ARTICLE, AN ARTICLE THAT HAS A HYBRID-TYPE COATING AND A CONTACT LENS |
US8039026B1 (en) | 1997-07-28 | 2011-10-18 | Johnson & Johnson Consumer Companies, Inc | Methods for treating skin pigmentation |
US6217171B1 (en) | 1998-05-26 | 2001-04-17 | Novartis Ag | Composite ophthamic lens |
US6500481B1 (en) | 1998-06-11 | 2002-12-31 | Johnson & Johnson Vision Care, Inc. | Biomedical devices with amid-containing coatings |
US8106094B2 (en) | 1998-07-06 | 2012-01-31 | Johnson & Johnson Consumer Companies, Inc. | Compositions and methods for treating skin conditions |
US8093293B2 (en) | 1998-07-06 | 2012-01-10 | Johnson & Johnson Consumer Companies, Inc. | Methods for treating skin conditions |
EP1048304A1 (en) * | 1999-04-30 | 2000-11-02 | Novartis AG | Neutral coatings |
US6630243B2 (en) * | 1999-05-20 | 2003-10-07 | Bausch & Lomb Incorporated | Surface treatment of silicone hydrogel contact lenses comprising hydrophilic polymer chains attached to an intermediate carbon coating |
US6200626B1 (en) * | 1999-05-20 | 2001-03-13 | Bausch & Lomb Incorporated | Surface-treatment of silicone medical devices comprising an intermediate carbon coating and graft polymerization |
FR2796560A1 (en) * | 1999-07-21 | 2001-01-26 | Inst Nat Sciences Appliq | PROCESS FOR TREATING AN OBJECT OR MATERIAL, TO ENSURE ITS BIOCOMPATIBILITY, WITH LOW BIOLOGICAL ADHERENCE |
FR2796559B1 (en) * | 1999-07-21 | 2002-09-13 | Inst Nat Sciences Appliq | PROCESS FOR TREATING AN OBJECT OR MATERIAL, TO PROVIDE IT WITH BIOCOMPATIBILITY, WITH LOW BIOLOGICAL ADHESION |
US7985404B1 (en) | 1999-07-27 | 2011-07-26 | Johnson & Johnson Consumer Companies, Inc. | Reducing hair growth, hair follicle and hair shaft size and hair pigmentation |
AU6397800A (en) * | 1999-08-03 | 2001-02-19 | Miles A. Galin | Polysaccharide coating of contact lenses |
US6478423B1 (en) | 1999-10-12 | 2002-11-12 | Johnson & Johnson Vison Care, Inc. | Contact lens coating selection and manufacturing process |
CA2387021C (en) * | 1999-10-12 | 2009-09-01 | Johnson & Johnson Vision Care, Inc. | Contact lens coating selection and manufacturing process |
EP1095965B1 (en) * | 1999-10-27 | 2005-02-09 | Novartis AG | Process for the modification of a material surface |
JP2001163933A (en) | 1999-10-27 | 2001-06-19 | Novartis Ag | Method for moldifying surface of material |
ATE283733T1 (en) * | 1999-10-27 | 2004-12-15 | Commw Scient Ind Res Org | COATING PROCESS |
DE60106491T2 (en) * | 2000-10-16 | 2005-10-13 | Novartis Ag | PROCESS FOR SURFACE COATING OF MATERIALS |
US8431550B2 (en) | 2000-10-27 | 2013-04-30 | Johnson & Johnson Consumer Companies, Inc. | Topical anti-cancer compositions and methods of use thereof |
SE0004532D0 (en) * | 2000-12-07 | 2000-12-07 | Caldwell Karin Dahlgren | Use of mucin |
US7192615B2 (en) | 2001-02-28 | 2007-03-20 | J&J Consumer Companies, Inc. | Compositions containing legume products |
US6702983B2 (en) * | 2001-05-15 | 2004-03-09 | Bausch & Lomb Incorporated | Low ionic strength method and composition for reducing bacterial attachment to biomaterials |
DE10223310A1 (en) * | 2002-05-24 | 2003-12-11 | Biotronik Mess & Therapieg | Process for coating implants with a polysaccharide layer |
US6958169B2 (en) * | 2002-12-17 | 2005-10-25 | Bausch & Lomb Incorporated | Surface treatment of medical device |
JP4703954B2 (en) * | 2003-09-04 | 2011-06-15 | 財団法人浜松科学技術研究振興会 | Method for hydrophilic treatment of substrate and hydrophilic substrate |
US8394338B2 (en) | 2004-04-26 | 2013-03-12 | Roche Diagnostics Operations, Inc. | Process for hydrophilizing surfaces of fluidic components and systems |
EP1591778A1 (en) | 2004-04-26 | 2005-11-02 | Roche Diagnostics GmbH | Electrochemical gas sensor with hydrophilic membrane coating |
DE102004057155B4 (en) * | 2004-11-26 | 2007-02-01 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Process for the chemical functionalization of surfaces by plasma polymerization |
US20060182981A1 (en) * | 2005-02-16 | 2006-08-17 | Debergalis Michael | Antimicrobial fluoropolymer film, laminates and articles and process for making thereof |
WO2007056856A1 (en) * | 2005-11-16 | 2007-05-24 | UNIVERSITé LAVAL | Process for producing anto-fog coating |
EP1847316A1 (en) * | 2006-04-19 | 2007-10-24 | Eppendorf Array Technologies SA (EAT) | Method for stabilizing functional groups on a surface of a polymer used as solid support for making microarrays |
ATE532089T1 (en) * | 2007-02-09 | 2011-11-15 | Novartis Ag | CROSS-LINKABLE POLYIONIC COATINGS FOR CONTACT LENSES |
US8679859B2 (en) * | 2007-03-12 | 2014-03-25 | State of Oregon by and through the State Board of Higher Education on behalf of Porland State University | Method for functionalizing materials and devices comprising such materials |
US20100255625A1 (en) * | 2007-09-07 | 2010-10-07 | Fujifilm Manufacturing Europe B.V. | Method and apparatus for atomic layer deposition using an atmospheric pressure glow discharge plasma |
US20090142292A1 (en) * | 2007-12-03 | 2009-06-04 | Blackwell Richard I | Method For The Mitigation of Symptoms of Dry Eye |
WO2009092726A1 (en) * | 2008-01-23 | 2009-07-30 | Novartis Ag | Method for coating silicone hydrogels |
US8460743B2 (en) * | 2008-03-18 | 2013-06-11 | Novartis Ag | Coating process for ophthalmic lenses |
US8506944B2 (en) | 2008-05-07 | 2013-08-13 | The Regents Of The University Of California | Replenishment and enrichment of ocular surface lubrication |
RU2510274C2 (en) | 2008-05-07 | 2014-03-27 | Дзе Реджентс Оф Дзе Юниверсити Оф Калифорния | Therapeutic recovery and enhancement of ocular surface wetting |
JP5340823B2 (en) * | 2008-06-24 | 2013-11-13 | ナガセ医薬品株式会社 | Medical lubricant |
WO2010077708A1 (en) | 2008-12-30 | 2010-07-08 | Bausch & Lomb Incorporated | Packaging solutions |
US8454689B2 (en) | 2008-12-30 | 2013-06-04 | Bausch & Lomb Incorporated | Brush copolymers |
US8419792B2 (en) | 2008-12-30 | 2013-04-16 | Bausch & Lomb Incorporated | Brush copolymers |
CN102597856B (en) * | 2009-11-04 | 2014-07-23 | 诺华股份有限公司 | A silicone hydrogel lens with a grafted hydrophilic coating |
TWI483996B (en) * | 2009-12-08 | 2015-05-11 | Novartis Ag | A silicone hydrogel lens with a covalently attached coating |
TWI707926B (en) | 2010-07-30 | 2020-10-21 | 瑞士商愛爾康公司 | Readily-usable silicone hydrogel contact lenses |
US9244195B2 (en) * | 2011-06-09 | 2016-01-26 | Novartis Ag | Silicone hydrogel lenses with nano-textured surfaces |
JP6017572B2 (en) | 2011-10-12 | 2016-11-02 | ノバルティス アーゲー | Method for producing UV-absorbing ophthalmic lens by coating |
HUE027313T2 (en) | 2011-11-15 | 2016-10-28 | Novartis Ag | A silicone hydrogel lens with a crosslinked hydrophilic coating |
SG11201407327VA (en) | 2012-06-14 | 2014-12-30 | Novartis Ag | Azetidinium-containing copolymers and uses thereof |
US9395468B2 (en) | 2012-08-27 | 2016-07-19 | Ocular Dynamics, Llc | Contact lens with a hydrophilic layer |
EP2931504B1 (en) | 2012-12-11 | 2018-09-26 | Novartis AG | Method for applying a coating onto a silicone hydrogel lens |
WO2014095690A1 (en) | 2012-12-17 | 2014-06-26 | Novartis Ag | Method for making improved uv-absorbing ophthalmic lenses |
WO2015073758A1 (en) | 2013-11-15 | 2015-05-21 | Ocular Dynamics, Llc | Contact lens with a hydrophilic layer |
US9708087B2 (en) | 2013-12-17 | 2017-07-18 | Novartis Ag | Silicone hydrogel lens with a crosslinked hydrophilic coating |
WO2015131032A1 (en) * | 2014-02-28 | 2015-09-03 | Momentive Performance Materials Inc. | Tie coat composition and antifouling system |
US10875235B2 (en) | 2014-04-01 | 2020-12-29 | The Regents Of The University Of California | Bactericidal surface patterns |
CN104292489B (en) * | 2014-08-08 | 2017-07-25 | 苏州卫鹏机电科技有限公司 | A kind of surface modifying method for improving footwear material adhesive strength and application thereof |
EP3186070B1 (en) | 2014-08-26 | 2019-09-25 | Novartis AG | Method for applying stable coating on silicone hydrogel contact lenses |
WO2016032940A1 (en) | 2014-08-26 | 2016-03-03 | Novartis Ag | Poly(oxazoline-co-ethyleneimine)-epichlorohydrin copolymers and uses thereof |
EP3229851A4 (en) | 2014-12-09 | 2018-08-01 | Tangible Science LLC | Medical device coating with a biocompatible layer |
CA2978635A1 (en) | 2015-03-11 | 2016-09-15 | University Of Florida Research Foundation, Inc. | Mesh size control of lubrication in gemini hydrogels |
WO2017037610A1 (en) | 2015-09-04 | 2017-03-09 | Novartis Ag | Method for producing contact lenses with durable lubricious coatings thereon |
PL3383631T3 (en) | 2015-12-03 | 2020-03-31 | Novartis Ag | Contact lens packaging solutions |
CN108367517A (en) | 2015-12-15 | 2018-08-03 | 诺华股份有限公司 | Method for producing the haptic lens with lubricated surface |
EP3391101B1 (en) | 2015-12-15 | 2020-07-08 | Alcon Inc. | Method for applying stable coating on silicone hydrogel contact lenses |
WO2017156460A1 (en) | 2016-03-11 | 2017-09-14 | The Regents Of The University Of California | Synthetic polymeric implantable artificial cornea device incorporating nanopatterns |
US11484028B2 (en) | 2016-03-14 | 2022-11-01 | The Regents Of The University Of California | Fabrication of nano-structures on multiple sides of a non-planar surface |
MY189378A (en) | 2016-10-31 | 2022-02-08 | Alcon Inc | Method for producing surface coated contact lenses with wearing comfort |
KR102595791B1 (en) | 2017-06-07 | 2023-10-31 | 알콘 인코포레이티드 | silicone hydrogel contact lenses |
CN110709731B (en) | 2017-06-07 | 2022-05-24 | 爱尔康公司 | Silicone hydrogel contact lenses |
IT201700075956A1 (en) * | 2017-07-12 | 2019-01-12 | Mediplasma S R L | Covalent immobilization of heparin on contact lenses (LAC) and devices of medical-surgical interest treated via plasma |
US10809181B2 (en) | 2017-08-24 | 2020-10-20 | Alcon Inc. | Method and apparatus for determining a coefficient of friction at a test site on a surface of a contact lens |
US10828394B2 (en) | 2017-09-13 | 2020-11-10 | The Regents Of The University Of California | Anti-bacterial anti-fungal nanopillared surface |
US11086049B2 (en) * | 2017-10-03 | 2021-08-10 | The Regents Of The University Of California | Anti-microbial bandage contact lens with ocular drug delivery |
US11029446B2 (en) | 2017-12-13 | 2021-06-08 | Alcon Inc. | Method for producing MPS-compatible water gradient contact lenses |
DE102018101911A1 (en) * | 2018-01-29 | 2019-08-01 | Pinion Gmbh | Torque detection assembly and gear unit for a muscle powered vehicle |
JP2022517692A (en) | 2019-01-29 | 2022-03-09 | ボシュ・アンド・ロム・インコーポレイテッド | Packaging solution for contact lenses |
WO2020159690A1 (en) | 2019-01-30 | 2020-08-06 | Bausch & Lomb Incorporated | Crosslinked polymeric network and use thereof |
JP2022530253A (en) | 2019-04-29 | 2022-06-28 | ボシュ・アンド・ロム・インコーポレイテッド | Glycophospholipid polymer network and its use |
US11795320B2 (en) | 2019-09-20 | 2023-10-24 | Bausch + Lomb Ireland Limited | Grafted polymer and use thereof |
EP4017346A1 (en) | 2019-11-04 | 2022-06-29 | Alcon Inc. | Contact lenses with surfaces having different softness |
AU2020408087B2 (en) | 2019-12-16 | 2023-10-05 | Alcon Inc. | Wettable silicone hydrogel contact lenses |
EP4189469A1 (en) | 2020-07-28 | 2023-06-07 | Alcon Inc. | Contact lenses with softer lens surfaces |
CN111729130B (en) * | 2020-08-06 | 2021-07-20 | 四川大学 | Artificial lens coating with excellent biological anti-fouling performance and preparation method thereof |
WO2022034010A1 (en) | 2020-08-10 | 2022-02-17 | Bausch + Lomb Ireland Limited | Packaging solutions |
US20220372391A1 (en) | 2021-04-22 | 2022-11-24 | Alcon Inc. | Method for applying a coating onto a non-silicone hydrogel lens |
CZ2021473A3 (en) * | 2021-10-08 | 2022-06-22 | Technická univerzita v Liberci | Modification of geopolymer material to increase water wettability |
US20230159202A1 (en) | 2021-11-23 | 2023-05-25 | Bausch + Lomb Ireland Limited | Method for making a preservative-free packaged ophthalmic device product |
WO2024038390A1 (en) | 2022-08-17 | 2024-02-22 | Alcon Inc. | A contact lens with a hydrogel coating thereon |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4373009A (en) * | 1981-05-18 | 1983-02-08 | International Silicone Corporation | Method of forming a hydrophilic coating on a substrate |
IE55284B1 (en) * | 1982-05-14 | 1990-08-01 | Astra Meditec Ab | Articles exhibiting a biocompatible surface layer and process for providing articles with such a surface layer |
US5258041A (en) * | 1982-09-29 | 1993-11-02 | Bio-Metric Systems, Inc. | Method of biomolecule attachment to hydrophobic surfaces |
AU566085B2 (en) | 1984-06-04 | 1987-10-08 | Terumo Kabushiki Kaisha | Medical instrument with surface treatment |
SE442820B (en) * | 1984-06-08 | 1986-02-03 | Pharmacia Ab | GEL OF THE CROSS-BOND HYALURONIC ACID FOR USE AS A GLASS BODY SUBSTITUTE |
FR2649404B1 (en) * | 1984-08-23 | 1994-05-20 | Universal High Technologies | PROCESS FOR HYDROPHILIC COATING OF PLASTIC MATERIALS AND ITS MEDICAL APPLICATIONS |
US5037677A (en) | 1984-08-23 | 1991-08-06 | Gregory Halpern | Method of interlaminar grafting of coatings |
GB2163439B (en) | 1984-08-23 | 1988-04-27 | Bostik Ltd | Adhesive bonding |
US4663233A (en) * | 1985-10-24 | 1987-05-05 | Universal High Technologies | Lens with hydrophilic coating |
US4929685A (en) * | 1986-06-07 | 1990-05-29 | Nippon Oil And Fats Co., Ltd. | Method for modifying the surface of polycarbonate resin |
US4810638A (en) * | 1986-07-24 | 1989-03-07 | Miles Inc. | Enzyme-labeled antibody reagent with polyalkyleneglycol linking group |
WO1988002623A1 (en) | 1986-10-17 | 1988-04-21 | Bio-Metric Systems, Inc. | Improvement of the biocompatibility of solid surfaces |
US4734475A (en) * | 1986-12-15 | 1988-03-29 | Ciba-Geigy Corporation | Wettable surface modified contact lens fabricated from an oxirane containing hydrophobic polymer |
JP2540159B2 (en) | 1987-06-11 | 1996-10-02 | 名糖産業株式会社 | contact lens |
FR2622201B1 (en) * | 1987-10-23 | 1990-03-23 | Essilor Int | WETABLE SILICON ELASTOMER SUITABLE FOR THE MANUFACTURE OF CONTACT LENSES |
WO1989011500A1 (en) | 1988-05-17 | 1989-11-30 | Commonwealth Scientific And Industrial Research Or | Hydrophilic non-swelling multilayer polymeric materials and process for their manufacture |
JP2745558B2 (en) | 1988-09-17 | 1998-04-28 | 東レ株式会社 | Lubricious medical materials |
ATE175681T1 (en) * | 1988-10-17 | 1999-01-15 | Hemasure Inc | METHOD FOR THE COVALENT SURFACE MODIFICATION OF HYDROPHOBIC POLYMERS AND PRODUCTS THEREOF |
JP3010232B2 (en) | 1988-12-29 | 2000-02-21 | 日本精化株式会社 | Biocompatible materials |
US5080924A (en) * | 1989-04-24 | 1992-01-14 | Drexel University | Method of making biocompatible, surface modified materials |
JP2620378B2 (en) | 1989-05-11 | 1997-06-11 | 鐘淵化学工業株式会社 | Method for producing medical device having surface with excellent biocompatibility |
EP0601055B1 (en) * | 1991-08-16 | 2000-06-07 | GALIN, Miles A. | Medicament coated refractive anterior chamber ocular implant |
FR2682959A1 (en) * | 1991-10-29 | 1993-04-30 | Essilor Int | WETABLE BIOCOMPATIBLE MATERIALS BASED ON SILICON ELASTOMER AND PROCESS FOR THEIR PRODUCTION. |
IL106922A (en) | 1992-09-14 | 1998-08-16 | Novartis Ag | Composite materials with one or more wettable surfaces and process for their preparation |
US5374515A (en) * | 1992-11-13 | 1994-12-20 | Organogenesis, Inc. | In vitro cornea equivalent model |
IL109221A (en) | 1993-04-12 | 1998-04-05 | Johnson & Johnson Vision Prod | Polymeric ophthalmic lens with crosslinker containing saccharide residue |
-
1993
- 1993-09-06 IL IL10692293A patent/IL106922A/en not_active IP Right Cessation
- 1993-09-08 SG SG1996001084A patent/SG49616A1/en unknown
- 1993-09-08 WO PCT/EP1993/002420 patent/WO1994006485A1/en active IP Right Grant
- 1993-09-08 EP EP93919291A patent/EP0613381B1/en not_active Expired - Lifetime
- 1993-09-08 CZ CZ941463A patent/CZ146394A3/en unknown
- 1993-09-08 CA CA002122363A patent/CA2122363C/en not_active Expired - Fee Related
- 1993-09-08 EP EP00119879A patent/EP1060753A3/en not_active Withdrawn
- 1993-09-08 JP JP50775894A patent/JP3650394B2/en not_active Expired - Fee Related
- 1993-09-08 AT AT93919291T patent/ATE212864T1/en not_active IP Right Cessation
- 1993-09-08 DE DE69331539T patent/DE69331539T2/en not_active Expired - Fee Related
- 1993-09-08 PL PL93303779A patent/PL177980B1/en unknown
- 1993-09-08 NZ NZ255408A patent/NZ255408A/en unknown
- 1993-09-08 HU HU9401764A patent/HU216746B/en not_active IP Right Cessation
- 1993-09-13 CN CN93118995A patent/CN1052167C/en not_active Expired - Fee Related
- 1993-09-13 TW TW082107484A patent/TW311120B/zh active
- 1993-09-13 MX MX9305597A patent/MX9305597A/en not_active Application Discontinuation
- 1993-09-13 ZA ZA936728A patent/ZA936728B/en unknown
-
1994
- 1994-05-11 FI FI942204A patent/FI942204A/en unknown
-
1996
- 1996-02-14 US US08/601,420 patent/US6623747B1/en not_active Expired - Fee Related
-
2002
- 2002-07-05 JP JP2002196950A patent/JP2003062059A/en active Pending
-
2003
- 2003-02-19 US US10/368,693 patent/US6923978B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
HU216746B (en) | 1999-08-30 |
TW311120B (en) | 1997-07-21 |
FI942204A0 (en) | 1994-05-11 |
EP1060753A3 (en) | 2001-01-10 |
JP2003062059A (en) | 2003-03-04 |
EP0613381A1 (en) | 1994-09-07 |
WO1994006485A1 (en) | 1994-03-31 |
HU9401764D0 (en) | 1994-09-28 |
JP3650394B2 (en) | 2005-05-18 |
CZ146394A3 (en) | 1994-12-15 |
US6623747B1 (en) | 2003-09-23 |
FI942204A (en) | 1994-05-11 |
CN1088513A (en) | 1994-06-29 |
DE69331539T2 (en) | 2002-09-12 |
EP1060753A2 (en) | 2000-12-20 |
ATE212864T1 (en) | 2002-02-15 |
CN1052167C (en) | 2000-05-10 |
US20030175325A1 (en) | 2003-09-18 |
EP0613381B1 (en) | 2002-02-06 |
US6923978B2 (en) | 2005-08-02 |
IL106922A (en) | 1998-08-16 |
PL177980B1 (en) | 2000-02-29 |
CA2122363A1 (en) | 1994-03-31 |
HUT68002A (en) | 1995-05-29 |
ZA936728B (en) | 1994-03-14 |
MX9305597A (en) | 1994-05-31 |
SG49616A1 (en) | 2001-01-16 |
DE69331539D1 (en) | 2002-03-21 |
NZ255408A (en) | 1997-11-24 |
JPH07501256A (en) | 1995-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2122363C (en) | Coated composite material with wettable surface | |
US6586038B1 (en) | Process for the modification of a material surface | |
US6521352B1 (en) | Process for the modification of a material surface | |
US6582754B1 (en) | Coating process | |
EP1095711B1 (en) | Process for coating a material surface | |
EP1299753B1 (en) | Coated articles | |
US6465056B1 (en) | Process for coating a material surface | |
EP1084428B1 (en) | Organic articles with hydrophilic coating | |
EP0946220B1 (en) | Reactive coatings | |
EP1095966B1 (en) | Process for the modification of a material surface | |
US6468667B1 (en) | Ophthalmic molding | |
EP1095965B1 (en) | Process for the modification of a material surface | |
AU671671B2 (en) | Multilayer materials |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |